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Editorial
Lauren Sham (Meds 2014)

hey say that medical school is the time in whi ch yo u learn all
the " zebras" - the we ird, wacky and wonderfu l diseases that professo rs briefl y mention as an aside in lecture, with the hope that
one day you ' II spot the illusive bl ack and white stripes in the crowd.
They also say that you never forget every time yo u see a zebra. Thi s
seems to ring true in thi s Emergency and Criti cal Care issue, in which
two of our articles reference the sa me case of sudden death of a young
girl , but through di ffe rent lenses. O ne is through the eyes of our Zebra
Files editors, who carefu lly analyzed the anatomica l basis fo r the sudden
death. The other is through the eyes of Dr. Shiva Kaldindi, a pedi atric
emergency physician refl ecting on patients that have affected him in hi s
practice, during an interview with our Profil es editors.

T

However, what's common is common, especially in the emergency
room. Our editors have taken the "common" and put their own spin onto
it, revealing the story behind many issues in Emergency and Critical
Care. Roman Shapiro, Kim Fielding and Elaine Tang describe the medical trainee response to stressful situations, something that our second
year students may want to fa miliarize themselves with before heading
off into clerks hip. Melissa MacPherson and Laura Callan discuss novel
technological adva nces in communication, imaging and documentation
in emergency care that may come into practice by the time we become
physicians. Our Clini cal Procedures editors further explore one of these
technologies, Focused Assessment with Sonography for Trauma (FAST)
and its role in abdominal trauma. N iran Argintaru and Jonathan Fairbairn outline the clini cal, ethical and legal implications of Form I use,
which gives physicians the ability to hold a patient without consent in a
hospital. Our Interdi sciplinary Editors discuss the importance of interprofessional collaboration, particularl y in an acute care setting. Jaso n
Chan and Justine Denomme vividly describe how medicine was dramaticall y changed during the course of the French Revo lution, producing the fa ther of modem Emergency Medicine, Dominique Jean Larrey. Stephanie Gottheil and Charlotte Hunter present the importance of
breastfeeding in a unique li ght with its own set of challenges - for babies
in the NICU. Our Diagnostic Review team review the vast array of biomarkers for myocardial infarction , their pros, cons, and new techniques
to come.

to Contrast-Enhanced Echocardiography, pointing out appl ications in
assessing myocardial fl ow, imaging the peripheral vascul ature, and even
ultrasound-mediated gene and drug deli very with microbubbles. Yoan
Kago ma g ives an account of the use of transarterial chemoembolization in hepatocellul ar carcinoma, in particular through the wo rds of a
patient 's experience, a unique view that we do not hear often enough.
Finall y, Jean-Marc Beausoleil , a former paramedic, provides us with a
primer on EMS operations, with the ai m of increas ing our awareness of
the "pre-hospital setting" which most of us are unfa mili ar with .
We hope that our Emergency and Criti cal Care issue provides you
with a look at Emergency and Criti cal Care beyond the setting of the
everyday E R. Keep an eye out for those "zebras"- you might just encounter them.

In this issue we have al so expanded the scope of our feature articles to
include a broader array of topics, instead of being confined to the issue 's
theme . Thi s has prov ided an increased capability to showcase students'
work and opinions in a variety of fi elds. ln this issue, Yin Hui discusses
the new oral anticoagulants that have come to market, some of which
have promi sing features; but she cautions us to not forego Warfarin just
yet. Paul Kudlow and Daniel James describe a case of a schizophrenic
patient who presented with a silent acute abdomen, an atypical presentation which can lead to dangerous misdiagnoses in the emergency room.
Brennan Ballantyne and Josh Rosenblat provide us with an introduction
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A primer on EMS operations for physicians and
medical trainees
Jean-Marc Beausoleil, Pri mary Care Paramedic (Meds 2015)
Faculty Reviewer: Dr. Michael Lewell , MD , FRCPC (Division of Emergency Medicine)

here are two major theatres of emergency healthcare: the hospital , with which physicians and trainees are familiar, and the prehospital setting. As a result, many healthcare workers know little
about how the EMS system works, which can lead to confusion and
delays when interactions do occur. This ' primer ' attempts to increase
awareness of how Emergency Medical Services (EMS) are delivered
and structured in the province of Ontario.

T

O VERSIGHT AND DELEGATE D ACTS
Paramedics in Ontario are not currently part of the Regulated Health
Professions Act (RHPA), and lack their own regulatory college (this is
currently being examined, [I]). The Ministry of Health and Long Term
Care (MOHLTC) still holds responsibility for regulating the paramedic
profession. However, providing EMS has been the responsibi lity of upper-tier municipalities since 2000.2
The ability to perform therapies that are considered controlled acts
under the RHPA (e.g. administering a substance by injection or inhalation) are delegated to paramedics by physicians (Medical Directors)
through the seven MOHLTC Regional Base Hospital Programs in Ontario (see [3] for more information on delegation.)
Together, the seven Regional Medical Directors form the Medical
Advisory Committee that proposes new or revised medical directives.
Final approval is dependent on provincial and EMS service management
representatives, examining logistics and costs of implementation. The
Medical Directives are based on the best available evidence, considering the limited diagnostic tools and resources available in an ambu lance.
Treatment follows the specific conditions (e.g. fo r cardiac i chemia),
contraindications, dosing and schedu ling laid out in the medical directive for administration of the indicated drugs. However, a paramedic

may use their clinical judgement to determine the patient's symptoms
were from another cause (e.g. chest wall pain), and therefore that treatment is not initiated.
SCO PES O F P RACTICE
For each of the three designated scopes of paramedic practice in Ontario,
there are core medical directives, which must be provided by paramedics at that level , and auxiliary directives that are approved for use but
which may not be implemented by individual services.

Primary Care Paramedics (PCP)
The majority of paramedics in Ontario are PCP, requiring at least two
years of college education. To be competitive for entry to most paramedic programs today, some po t-secondary education is required. In addition to clinical placements in various settings, the final semester of the
program is a full time field placement with a certified paramedic acting
as preceptor. See Table I for a brief overview of PCP medical directives.
Medical Termination of Re uscitation (TOR) is a new protocol in
20 II . The intention is to remove the significant risk that is associated
with driving lights and siren by ceasing resuscitation when deemed medically futile . Resuscitation i initiated and, based on patient condition,
the paramedics may be required to contact a Base Hospital Physician
(BHP) via phone to discu the clinical situation and request a TOR
order, which is given (or not) at the BHP 's discretion .
The provincial stroke bypass protocol demonstrates how rapid prehospital as essment by EMS can be of significant benefit to patients. Patient presenting with a probable cerebrovascular accident (CVA) should
be brought directly to the nearest designated stroke centre, 'bypassing'
the nearest ED. The intent i to get patients that fit the protocol crite-

TABLE 1- PCP core and au xiliary medical directives

Continuous Positive Airway
Continuous Positive Airway Pressure
Dextrose (intravenous)

Epinephrine (nebul ized)
Semi-Automatic External Defibri llation

Supraglottic airway
IV access & 0.9% normal saline

Nausea & vomiting
Termi nation of Resuscitation

6

Dimenhydrinate
Medical and traumatic cardiac arrest protocols
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TABLE 2- ACP core and auxiliary medical directives
Note: All PCP skills are included in ACP skill sets (with the exception that some auxiliary PCP skill s are core ACP skills, and some shared skills
havedifferent indications)
.,.'.'• ~~:- -',~
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Cardiac ischemia

-,. ... ·- . :~ ~J. ~_,~__.~~~
Morphine

Cardiogenic shock

Dopamine

Symptomatic bradycardia

Atropine, *transcutaneous pacing & *dopamine

Tachydysrhythmias (non-sinus)

Yalsalva, *adenosine, *amiodarone/lidocaine,
*synchronised cardioversion

Seizure

Midazolam

Opiate overdose

*Naloxone

Hypoglycemia

Dextrose (intravenous) & glucagon

Fluid administration

IV & pediatric intraosseous

lntraosseous (adult) & central venous access
device (pre-existing)

Airway management

Naso- or orotracheal intubation

Supraglottic airway & *cricothyrotomy

'

'

- .-

~

.

~

,..t;'__._,.!!>J!.k':.....l ~~~-"'-"- ~ .••:'J 1 ._..._.,._,."\~.t,.-;....,.....•. ,_... _.t">_-. ,.y.nt

Tension pneumothorax

*Needle thoracostomy

Pain management (specific indications)

Morphine & fentanyl

Airway obstruction

Removal with laryngoscope & Magill forceps

Cardiac arrest

Manual Defibrillation, epinephrine,
amiodarone/lidocaine

Return of Spontaneous Circulation

Dopamine

•4.

Combative patients

*Midazolam

Procedural sedation (intubation, pacing)

Midazolam

* Attempts to patch to a base hospital physician required before performing this skill. See [ 11] for more information.
ria rapidly assessed by neurologists and CT scanned so that occlusive
strokes can be treated with the thrombolytic tPA (Tissue Plasminogen
Activator).
Some regions have also implemented STEMI (ST (segment) Elevated Myocardial Infarction) bypass protocols, based on the fact that paramedics at most EMS services are trained to obtain and interpret 12-lead
ECGs for ST segment changes. If the patient falls within the protocol
criteria, the paramedics 'patch ' directly to the interventional cardiologist, who can then direct the crew to bypass the ED and bring the patient
directly to the catheterization lab for angioplasty. Unlike the stroke protocol, STEMI bypass is not province-wide as far fewer hospitals have
the necessary resources.
Prehospital acquired 12-lead ECGs are listed as a class I recommendation in the American Heart Association guidelines, having been
shown to decrease door-to-need le time.4 Additionally, interpretations are
usually obtained before treatment has been initiated and may demonstrate findings that hospital ECGs do not, such as ST segment changes
or arrhythmias that may have resolved. 5

Advanced Care Paramedics (ACP)
PCP can later apply to an ACP certificate program, usually after writing entry examinations. Many programs also require prior work experience as a PCP (e.g. Fanshawe College requires 4000 hours within the
last three years 6). The ACP scope of practice includes all the controlled
acts available to PCPs, along with a broad suite of additional delegated
acts; however, not all EMS services employ ACPs. See Table 2 for a
brief overview of ACP delegated acts.

Critical Care Paramedics (CCP)
ACPs with flight-medic certification can apply to the CCP program

offered by the Omge Academy of Transport Medicine (see [7] for further information). CCP have a very broad scope of practice, including all
ACP controlled acts and many that are CCP unique (e.g. chest X-ray and
lab value interpretation, blood product administration, many more drugs
including thrombolysis). 8 A BHP is always on duty to provide on-line
medical direction for CCPs. These paramedics are primarily employed
doing critical care land and air transfers, or in the case of the helicopters,
for critical calls or locations that can 't feasibly be serviced by land ambulances (e.g. Pelee Island).
EMS OPERATIONS

Central Ambulance Communications Centers (CACCs)
Whi le paramedics have authority over patient care, CACCs have authority over ambulance movements. Communications Officers at CACC
act either as 911 call-takers or as ambulance dispatchers .
Dispatchers are responsible for ensuring timely EMS service and
maintaining response capacity. They track all ambulances in their zone,
and as units are dispatched to calls, other units are moved to cover the
area of responsibility. The dispatcher must maintain constant awareness
of all resources, and liaise as needed with other emergency services and
hospitals. For this to be possible, ambulance movements need to be
tightly linked to CACC
The ongoing acute-care bed shortages in hospitals have bad a significant impact on EMS services, as paramedic crews with low-acuity
patients may end up on ' stretcher delay ' for hours waiting to transfer
care. This is particularly a problem in urban areas, and results in reduced
emergency coverage.
The recent growth in private patient transfer companies has led to
some confusion for other health care workers, who may expect an ambu-
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lance to transfer patients on both inbound and return trips. Due to the
demands on the ystem di scussed above, it is rare today fo r non-acute
transfers to be done by EMS. In any patient transfer by ambulance, acute
or non-ac ute, the EMS crew must transfer care and return immediately
to emergency coverage, their primary duty.

Allied Emergency Services
Fire personnel province-wide are responsible for rescue and extrication. Many fire services also have tiered response agreements with
local EMS whereby they are di spatched to certain high-acui ty call s to
decrease average response time (as the ir base may be c loser to a call)
and provide manpower to the two paramedics. lt is important to note that
paramedics maintain overall control of care as their medica l tra in ing far
exceeds that of fire personnel.
Police officers and paramedi cs also wo rk together regularl y, a lthough
police rarely arri ve specificall y to assi tin patient care. They are particularl y important fo r the safety of both the patient and emergency personnel when dea ling with combative patients or those with menta l health
issues, as they have the power to detain under the Mental Health Act or
use restraints.

Air Ambulance
Air ambulances can either be requested immediately by the CACC
recei ving the 9 11 call , or by on-scene paramedics based on a series of
operational and clinical criteri a.9 The pilots fi r t determine whether it i
safe to make the fli ght; only then do the fli ght paramedics receive information about the call.

20 10; I 22:S787-8 I 7
5. Davis, MT, Lewe ll, M, McLeod, S, Dukelow, A . A prospective Evaluation of
the Util ity of the Prehospita l I 2-Lead Electrocardiogram to Change the Management of Patients in the Emergency Department. Prehospital Emergency
Care. 20 12; 16( 1): 167
6. Fanshawe College. Advanced Care Paramedic 2012/2013- Admissions Requirements [Internet). [C ited January 29 201 2]. Ava ilable from www.fansha wee.ca/progra ms-co urses/ fu 11-ti me- program s/ad p 1/adm iss ion-requirements .
7. Ornge Academy of Transport Medici ne. Criti cal Care Paramedic (CCP) Program [Internet) . [Ci ted Janu ary 29, 20 12) Ava il able fro m http://www.omge.
cal Academy/Pages/Co urses .aspx .
8. Ministry of Hea lth and Long Term Care. Controll ed Acts Under Regulation
257/00 [Internet]. 2011 , Jul y 28 [cited January 29, 20 12]. Avail able from
http://www.health .gov.o n.ca/e ngl ish/pub Iic/program/ehs/leg/reg_ 257 _ 00.
html .
9. Emergency Hea lth Services Branch, M in istry of Hea lth and Long Term Care.
Basic Life Support Patient Care Standards version 2.0- Air Ambulance Utilization Standard. Toronto, 0 : Queen 's Prin ter for Ontario; 2007. pp. 1-23
- 1-29
I 0. Brown, JB , tassen, NA, Bankey, PE, Sangosanya, AT, Cheng, JD, Gestring,
ML. He licopters and the Civilian Trauma System: National Utilization Pattern s Demonstrate Improved Outcomes After Traumati c Injury. The Journal
of Trau ma: Inj ury, Infection and Cri tica l Care. 20 10;69(5): I 030-6
I I. Emergency Health ervices Branch, Mi nistry of Health and Long Term Care.
Advanced Life upport Patient Care tandards version 3.0. Toronto, ON :
Q ueen 's Pri nter for Ontario; 20 I I . I 99 p.

One maj or advantage of the air ambulance is in trauma, as it's able
to rapidl y transport patients from rural areas to a hi gh-level trauma centre.10 In Ontario the air ambulance can also perform ' modifi ed scene
calls,' where a critical pati ent that bas successfull y reached the nearest
ED is met at the hospital by the helicopter. The fli ght paramedics can
then assume care from the ED staff and bypass to a trauma centre.

~~\~

CONCLUSION
Ambulances often arri ve at scenes of chaos. Paramedics, w ith the assistance of, CACC, med ical directors, and many other factors, manage to
restore some form of order and transport those requiring medi cal care
to the waiting ED staff. Hopefu lly, this primer has managed to ha ve
success full y increased the reader 's understanding of the unique roles of
EMS and paramedi cs in Ontari o's hea lthcare system, as we ll as some
of the unique challenges that mnst be faced in responding e ffecti vely to
medical emergenc ies outside of the hospi tal environment.
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Painless amusement: the case of a man with
schizophrenia presenting to the emergency
department
Paul A. Kudlow (Meds 2013), BSc. Daniel James (Meds 2013) MA, BA, BSc.
Faculty Reviewer: Dr. RogerS. Mcintyre, MD , FRCPC (Department of Psychiatry, University of Toronto)
chizophrenia, a severe mental illness affecting an estimated 0.7%
of the world's population, is characterized by myriad symptoms,
broadly including derangements in cognition, perception, and
emotional responsiveness. 1 Along with these broad alterations, pain insensitivity, or hypoalgesia, has been reported in schizophrenia since the
early 20th century.2•3 Despite these early and ongoing case reports, little
progress has been made to elucidate the underlying mechanisms driving
this peculiar symptomatology. Herein, we explore a recent case report
describing a patient with schizophrenia presenting with a si lent acute
abdomen. Following this, we review the extant literature examining the
underlying pathophysiology of hypoalgesia in schizophrenia. We conclude by proposing a novel mechanism to explain such an effect, as well
as offer clinical recommendations to emergency physicians regarding
appropriate management of severely mentally ill patients presenting to
the emergency department.

S

In this recent case report, we examine Mr. T, a middle-aged man with
schizophrenia, who despite a perforated gastric ulcer and an active upper
gastrointestinal bleed, presented without pain, abdominal rigidity, or anorexia.4 Mr. Twas a cachectic, disoriented male, taken to the emergency
department. His vital signs were stable on arrival. Psychiatry confirmed
schizophrenia and risperidone was started. The morning after admission
to Psychiatry, he was tachycardic, hypotensive, hungry, but not in pain.
Abdominal examination was benign, but CT found free air under both
hemidiaphragms. He was taken for emergent exploratory laparotomy.
The peritoneal fluid was purulent, and the stomach contained two perforated pyloric ulcers. The gastroduodenal artery was bleeding actively.
Mr. T underwent corrective surgery, and was discharged from hospital
in stable condition.
In this case, Mr. T experienced a silent acute abdomen. Although
extremely rare in the general population, a painless acute abdomen, as
well as other insensitivities to physical sensations, is not as uncommon
in psychotic patients. In a study of79 patients with psychosis, 21.4% of
those with acute perforated ulcers and 36.8% of those with acute appendicitis presented without any complaint of pain. 5 Not surprisingly, this
atypical presentation often leads to dangerous misdiagnosis, resulting in
higher rates of morbidity (56% in patients with schizophrenia vs. 16%
in the population as a whole) and mortality (4% in patients with schizophrenia vs. 1.8% in the general population).6 Moreover, pain insensitivity may help to explain why individuals with schizophrenia are less
likely to complain of physical symptoms related to diabetes, arthritis,
infectious disease, etc.6 As reported in this case, instead of the classic
sign of pain, patients with schizophrenia often present with worsening
positive symptoms, including increasing severity of hallucinations, delusions, etc. 7
How do we explain the hypoalgesia experienced by Mr. T and other
similar patients with schizophrenia? One tactic of inquiry is to explore

mechanisms in other medical presentations where pain insensitivity is
present. For example, certain stressful events, such as traumatic injuries are known to result in transient hypoalgesia secondary to increased
endorphin production.8 It has been postulated that increased levels of
endorphins may account for decreased sensitivity to pain and other
symptoms of schizophrenia.4 However, no such correlation between hypoalgesia and levels of endogenous opioids have been found in patients
with schizophrenia.9 Other more recent hypotheses have utilized the recent advances in our understanding of the neurobiology of schizophrenia to explain the hypoalgesic effect. Schizophrenia is known to involve
dysfunction of the dopamine, glutamate, and more recently discovered
cannibinoid systems. 1•10 These neurotransmitters have also been shown
to be integral to the modulation of pain perception. 11 Some investigators
have postulated that certain neurotransmitter dysfunction seen in schizophrenia, particularly in the dopaminergic and cannibinoid systems, may
underlie the deficits in pain perception. 15 However, the evidence is limited by small sample sizes, generalizabi lity, and relatively inconsistent
data. 15 Further research is needed to elucidate causation between the
broad neurotransmitter dysfunction seen in schizophrenia and the specific hypoalgesic effect seen in this case.
Here we move away from the neurobiological explanations and offer a novel explanation that seeks to unite some of the known neuropsychological perceptual deficits in schizophrenia with the hypoalgesic effect seen in this case. We began by re-examination of the "first
rank symptoms" originally proposed by psychiatrist, Kurt Schneider
( 1887- 1967). 12 First rank symptoms, now mostly re-classified as "positive symptoms," can be broadly characterized by the feeling of being
controlled by an external force . This often manifests in the patient with
frank hallucinations and delusions. In 2000, Blakemore et al. published
an interesting seminal work that correlated the severity of first rank
symptoms with the unique ability to tickle oneself. 13 Individuals suffering from the most severe hallucinations and delusions were found to
be more likely to have an ability to tickle themselves . Based on these
results, researchers proposed a feed-forward model : in normal individuals, a central efferent copy of a motor command (tickling command)
is actively compared to a re-afferent signal (tickling sensation) arising
from an individual 's action. The signals are compared in a signal "integrator." The integrator actively compares the difference between the two
signals. If none exist, the signals cancel out, and we perceive nothing (as
is the case when normal individuals try to self tickle) . Yet once there is
a difference, the integrator generates a signal, which we perceive as a
sensation. Given that patients with schizophrenia have an ability to selftickle, yet possess intact efferent and re-afferent pathways, investigators
postulated that these individuals may have a problem with the central
"signal integrator" - causing it to generate erroneous signals. This forward mechanism for knowing is thought to underlie our cognitive ability
to differentiate between self-produced and externally produced stimuli
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- an abi lity thought to be impaired in schizophrenia.
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This model was later validated by a recent study completed by Voss
et al. Investigators found that patients with schizophrenia made global
perceptual errors - often fa iling to associate their own actions with external events leading to persistent misinterpretation of endogenously and
exogenously driven stimuli.14 Moreover, severi ty of positive symptoms
in the patients was correlated with increasing amounts of global perceptual errors.
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Intriguingly, in the case of Mr T., as well as in other si milar case reports6.8·1S, si lent acute abdomen often presents in the context of increasing severity of positive symptoms. In the past, authors postulated that the
onset of an acute abdomen (overwhelmingly painful stimu lus) triggers
increasing positive symptoms (hallucination and delusions). Yet given
the model delineated above, it is also possible, and logical to conclude
an opposite temporal relationship. A high degree of positive symptoms
in mental illness may lead to global perceptual errors - this in tum may
be responsible for varying degrees of pain insensitivity.
Applying the model to the case, Mr. T may have a deficit in his central "signal generator," causing him to misinterpret the external pain
stimulus of his acute abdomen as that of a stimu lus he was creating himself. Thus, similarl y to a normal individual attempting to tickle himse lf,
Mr T simply did not feel or react. We propose that this hypoalgesia could
be secondary to the global perceptual deficits typified in schizophrenia.
This is in contrast to the primary mechanisms as previously described .
More research however needs to be done in this area to fully elucidate
how global errors in the feed forward mechanism may lead to hypoalgesia as seen in schizophrenia.
For example, a study, similar in design to the studies completed by
Blakemore and Voss et al. could be undertaken to exam ine whether the
ability to self-tickle (a validated proxy for global perceptual errors) was
associated with varying degrees of pain insensitivity. If the model presented in this discussion were valid, degree of pain insensitivity would
increase with higher responses to self-tick le. Extending this model
one step further, si nce self-tickle has been postulated to be secondary
to severity of positive symptoms 1\ patients with the highest degree of
positive symptoms would be expected to have the greatest amount of
pain insensitivity. Reduction of positive symptoms with administration
of anti psychotics would therefore be expected to reduce degree of pain
insensitivity. A study completed by Jochum et al. , examined the effect
of antipsychotics on the perception of pain in schi zophrenia. 16 Simi larly
to previous reports, investigators confirmed varying degrees of hypoalgesia in patients with schizophrenia. Accordingly, three days following
administration of antipsychotics, pain perception differences became
less apparent between patients with schizophrenia and healthy control .
The effect size was small (less than 5%). However, thi s wa likely confounded by the short measurement window of three days. Future studies,
extending the treatment mea urement window, may find a larger effect
size.
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ln conclusion, physicians must be aware of the potential atypica l presentation of a patient with schizophrenia in pain . This of course has implications for triage, assessment and treatment in the emergency department. Emergency physicians should maintain a high index of su pic ion
for acute abdomen and other painful conditions in seriously mentally
ill patients presenting with a high degree of po itive sym ptoms or any
indication of decreased pain sensation . Although a thorough head-to-toe
physica l exam is essential, in these patients it can be mi sleading. Therefore, as evidenced by the case of Mr. T, close scrutiny of any laboratory
investigations or imaging studies will help to ensure that these challenging patients receive appropriate care.
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Transarterial chemoembolization: the treatment,
the evidence, and a patient's experience
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ABSTRACT
Hepatocellular carcinoma is a rare, yet devastating diagnosis with limited treatment options. For selected patients, transarterial chemoembolization (TACE) is a therapeutic choice which allows for treatment that
is minimally-invasive, directed, and reduces mortality. Nonetheless, it
represents an innovative approach to cancer treatment and investigating its efficacy from both a biomedical and biopsychosocial perspective
warrant discussion.

BACKGRO UND:
In Canada, primary liver cancer (PLC) is an uncommon diagnosis with
an incidence rate of 2.2 I I 00 000 individuals and approximately 1950
new cases were diagnosed in Canada in 2011. 1 Current statistics from
the Canadian Cancer Society indicate that the incidence rate of PLC has
increased by an average of 2.9% with an associated increase in mortality over the period spanning from 1998-2007. 2 Major risk factors for
PLC in Canada include alcohol-related cirrhosis, hepatitis C virus, and
hepatitis B virus. More recently, type 2 diabetes mellitus has been linked
as an risk factor for hepatocellular carcinoma.3 In developing nations,
the consumption of foods containing aftatoxins and parasitic infections
such as schistosomiasis and liver flukes represent additional risk factors .
Hepatocellular carcinoma (HCC) accounts for 85-90% of PLCs and
once detected, treatment options are often limited. This is due to the fact
that there is currently no PLC screening test and the signs and symptoms
of PLC are vague, non-specific, and often do not manifest until the disease is locally advanced or has metastasized. The symptoms include:
nausea, vomiting, loss of appetite, jaundice, hepatomegaly, weight loss,
and fatigue . It is estimated that the median survival time for untreated
HCC is less than 5 months and the 5-year relative survival rate after a
diagnosis ofPLC is approximately 18% in Canada. 2 · 4
After a diagnosis of HCC, the main therapeutic options are as follows:
Resection - for localized tumour in a liver that has retained adequate synthetic function . As much as 75% of a liver may be resected in an operation. Many patients are ineligible for resection
due to the size or number of liver lesions present or based on the
fact that the lesions have invaded into the liver 's blood supply.
Transplant - for non-metastatic disease with an appropriately
matched donor. This approach requires lifelong immunosuppression and is limited by the supply of available donor livers .
Other - cryosurgery, radiofrequency ablation, chemotherapy, radiation therapy. This category involves many cutting-edge therapies
which are still under investigation for their efficacy.

TRANSARTERIAL CHEMOEMBOLIZATION:
Transarterial chemoembolization (TACE) is a treatment for unresect-
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able HCC which fits into the latter category. It is performed by an interventional radiologist and involves percutaneous image-guided access
to selectively deliver a chemotherapeutic agent to the blood vessels
supplying a tumour. In this way, a tumour may be specifically targeted,
minimizing the systemic effects of chemotherapy (and the associated
side effects) while stunting or arresting tumour growth. It is a minimally
invasive approach that has been shown to improve survival for carefully
selected patients with unresectable HCC.5• 7 Patient selection is commonly based on prognostic scales such as the Child-Pugh score8 , Model
fo r End-Stage Liver Disease (MELD) 9 , or the Milan criteria 10 which
incorporate various markers of liver function, tumour characteristics,
and comorbidities.

A PATIENT'S EXPERIENCE
Patient X is a 63 -year-o ld gentleman with biopsy-proven HCC likely
secondary to hepatiti s C and alcoholic cirrhosis. At the time of presentation, there were no signs or symptoms of decompensated liver disease.
Initial bloodwork showed a mild elevation in transaminases and elevated ferritin . Other liver studies were unremarkable.
His initial imaging studies consisted of an abdominal ultrasound and
contrast CT which showed a 4.2 em rounded mass with evidence of
arterial enhancement (see Figure 1). A number of additional "suspicious
lesions" were identified within the liver. Lymphadenopathy was also
present in the periaortic area. These findings were suggestive of HCC.
The patient's case was then reviewed at the Liver Transplant Listing
Rounds by the hepatology team and transplant teams at London Health
Sciences Centre. Based on their opinions, the patient bad a MELD score
of 7 (low risk of mortality); however, based on location and arterial involvement, the tumours were not amenable to resection. Furthermore,
based on the number of lesions and size of the dominant lesion (the Milan criteria) the patient was ineligible for transplantation. His continued
intake of alcohol was also a contraindication to transplant. The decision
to undergo TACE in order to control tumour growth and down-stage the
tumour was made with the patient 's consent.

PROCEDURE:
Initial Procedure

Access to the common iliac artery was obtained via the right common
femoral artery through ultrasound guidance and the Seldinger technique.
A series of angiograms were then performed which demonstrated tumour growth when compared to the initial imaging studies. In this case,
the DEB-TACE chemoembolization delivery system was utilized. This
consists of drug-eluting beads (DEB) loaded with doxorubicin chemotherapy. These beads are mixed with Lipiodol, a contrast agent, and
then targeted at the tumour via angiography. Aside from a vasovagal
incident, the patient tolerated the procedure well. A post-procedure CT
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Post DEB-TACE #2

Figure 1: Initial CT showing large liver lesion

Figure 2: Post procedure CT showing hyperdensity consi stent with
DEB-TACE treatment

Figure 3: CT showing viable tumour in region previously treated by
DEB-TACE

Figure 4: CT show ing new areas of tumour growth

showed adequate tumour coverage (Figure 2) although resi dual tumour
was noted and a repeat DEB-TACE procedure was pl anned.

PATIENT'S EXPERIENCE:

Repeat Procedure
Prior to the repeat procedure, an additional CT was conducted, which
showed areas of arterial enhancement suggesting viable tumour (Figure
3) as well as multiple nodules representing new tumour foc i (Figure 4) .
The pati ent underwent a second DEB-TACE procedure in a simil ar fas hion to the initi al procedure. He tolerated the procedure well although a
second-degree Mobitz Type I heart bl ock and ri ght bundle branch block
were fo und incidentall y which were deemed not to req ui re treatment.
Repeat CT will be conducted approximately I month afte r this last procedure to assess the tumours.

12

The pati ent was agreeable to speaking about hi s condition and was interviewed w ith his w ife prior to his second DEB-TACE procedure. Informed consent was obtained . It was a unique opportunity to gai n insight
into the patient's thoughts regarding hi s treatment experience. The conversation was guided by the National Research Corporation 's &-dimensions of Patient Centered Care. 11 Major highlights of the conversation
were as fo llows:
The patient often felt that he was not actively informed or involved
in the decision making regarding his care. He was particularly upset by
the fact that little contact was made with him to discuss his diagnosis,
prognosis, and treatment option . He stated that it was, " a constant feeling of not knowing what I was getting into", and his wife confirmed that
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many of their questions were not addressed until her husband arrived for
his first DEB-TACE procedure despite the fact that his case had been
reviewed by the hepatology and transplant teams.

8. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg
1973 ;60(8):646-649.

Approximately S months elapsed between the patient's ultrasound
scan and his first DEB-TACE procedure. The patient and his wife could
not comment directly on whether they felt this wait was appropriate or
not. However, they were pleased with how quickly things progressed
from the time they initially met with the interventional radiologist and
the first procedure (approximately 3-weeks).

9. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A
model to predict poor survival in patients undergoi ng transj ugular intrahepatic portosystemi c shunts. Hepatology 2000;3 1(4):864-871.

His experience of the actual DEB-TACE procedure was positive and
the patient was impressed by how well he tolerated the procedure. He
stated that post-op pain was minimal ("I shook it off quickly") and that
he was able to work within 10 days. He had no qualms about consenting
for the repeat procedure and was surprised that he had minimal postprocedure complaints. These were mainly "weakness" and " pain" which
disappeared within 3-weeks.

I 0. Mazzaferro Y, Regalia E, Doci Ret al. Liver transplantation for the treatment
of small hepatocellular carcinomas in patients with cirrhosis. N Eng/ J Med
1996;334( 11 ):693 -699.
II . National Resea rch Corporation . Eight Dimensions of Patient Centered Ca re.
20 II. 12-8-20 II.

Although not curative, the patient was optimistic about the prospects
of his treatment. Given his lack of pre-op symptoms, it is difficult to
speculate over the survival benefit conferred by the DEB-TACE treatments; however, he remains asymptomatic after completing both rounds
of therapy. Follow-up CT will be schedu led for the coming months to
assess the success of the latest procedure.

CONCLUSIONS:
TACE is a viable option for patients with HCC who have exhausted
other treatment measures. This investigation highlights the fact that the
success of a procedure should be measured by both its clinical outcomes
and the patient 's overall satisfaction with their treatment experience. Regardless of complexity or efficacy, every procedure is subject to the same
core principles of patient care, with communication being paramount.
This case highlights what can occur if these channels are severed, leading to patient dissatisfaction despite a positive clinical outcome. TACE
requires the coordination of many different healthcare professionals and
teams, and including the patient in all discussions should be the norm if
we aim to maintain a high standard of care.
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INTRODUCTION
Contrast-enhanced echocardiography (CEE) is a method of echocardiography that utilizes the echogenicity of specific contrast media to
greatly increase the contrast obtained between blood and tissue. 1 The
concept, while over four decades old, has recently had increa ed attention in the clinical and preclinical realms of cardiovascular research due
to advances in technology that increase its utility.
EXPLANATION OF FUNCTION
Ultrasound functions by detecting the different den ities of tis ues in the
body based on their different responses to sound energy. CEE derives
its superior resolution from the use of contrast agents carried in the circulation that respond uniquely to sound energy. It was first realized by
Gramiak and Shah in 1968 that gas suspended in the blood stream alone
has advantages for imaging because the density differential between gas
and liquid phase provides optimal echo feedback patterns.2•3 However,
early contrast agents were too large to navigate through the capi llary
network of the lungs to the systemic circulation, and would prematurely
diffuse into tissues.3 Hence, newer agents were developed to be both
smaller and more stable. The so called " second generation" contrast
agents were composed of microbubbles of high density gas (usually
fluorocarbons) , encapsulated with a lipid or albumin coat. These microbubbles undergo volumetric osci llations under the pressure changes
induced by the ultrasound transmitter. Thi vibration produces energy
that can be picked up by the transducer and converted into an image.4
Microbubbles are very small , simi lar to the size of red blood cells, and
are able to navigate through caP.illary systems without becoming lodged .
They are strong enough to withstand " inertial cavitation," that is, large
oscillations in energy from the ultrasound that can destroy the bubbles.5
Older contrast agents could on ly enable CEE to image the right side
of the heart, limiting their role to the investigation of intracardiac or
intrapulmonary shunts. The second generation agents opened a door for
a new role ofCEE. 5
With advances in contrast agents, the ultrasound hardware technology had to adapt as well. Current CEE uses harmonic imaging that was
developed as a way for contrast-specific imaging modalitie to use lower
transmission power than that used for non-contrast imaging. This is required because high transmission power causes destruction of the microbubbles and impairment of tissue signals of the myocardium .6 Detection
methods now preferentially detect the harmonic signals given off from
the microbubble oscillations, minimize the signals from tissues, and provide a very high signal-to-noise ratio.5
ADVANTAGES AND DISADVANTAGES
The primary advantage of CEE technology lies in its superior image
quality when compared to native echocardiography, leading to more ac-
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curate measurements of entricular volumes, better detection of thrombi
or hypertrophy, and improved wall motion assessment. For example,
it bas been found that native ecbocardiograpby consistently underestimates left ventricle (LV) volumes when compared to magnetic resonance imaging (MRJ) tudies because it does not have the capacity to
image the trabeculation of the ventricular endocardium when measuring
volume. CEE results have been found to be equivalent with MRI due to
the ability of contra t agent to include the fine details of cardiac anatomy.6 The uperior imaging capabilitie of CEE are also demonstrated
in patients with poor ba eline quality native ecbocardiograms, a number
that can range from I 0-15% of those scanned. To our knowledge, all
studies conducted ha e found better results after CEE in these patients. 6
Another advantage of CEE i reproducibility of re ults. Native echocardiography has been criticized for high variability of measurements.
This has led to a shift in patients being referred for expensive and timeconsuming te t like Multi Gated Acquisition Scans (MUGA) and MRI
studies. CEE has reproducibility on par with MRJ, and is much less
expensive. 8 Even for technically difficult studies, such as stress echocardiography \ here inter-ob erver agreement can range from 43-100%,
CEE significantly improve the confidence of the interpretation, and
therefore, the reproducibility. 9
The main limitation to EE technology has been concerns regarding adver e event with the u e of contrast agents . In 2007 , the FDA
is ued Black Box warning to CEE contra t agents after reports of fatalities from cardiopulmonary reaction in at least 18 patients during
pro edures. 10 These afety concerns lowed adoption of the technology,
and po ed question about the future of CEE in the ecbocardiograpby
community. However, it should be noted that the risks of adverse events
are very low. ompari ons of the mortality rates of various cardiac procedure shows that mortality from CEE is (I : 145,000) excessively small
compared to coronary angiography (I : I 000) or even exercise electrocardiography (I :2500) . 10 The FDA currently recommends close monitoring
of vitals and
G for at least 30 minutes after administration of contrast
agent . 11 This monitoring time may be difficult for busy echo labs at
tertiary care centres, negating many of the time-saving benefits of echocardiography as an imaging modality.
INDICATIONS OF USE
A discussed above, CEE provides greater contrast between blood and
12
tissue. Therefore, organ border delineation may be determined with
greater resolution and accuracy. This is often applied to endocardial
border delineation, which allows for a better determination of wall
thickening or other wall abnormalities. 13 Contrast enhanced ultrasound
may al o be used to determine the perfusion of tissue. 14•15 As well it may
be used to estimate the volume of blood in a given organ or section of
tissue through the quantification of bubbles present and the extrapola-
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tion to a representative volume of blood. 16
With these concepts in mind and evaluation of the current clinical
evidence of usage, the American Society of Ecbocardiography (AS E)
publi shed a consensus statement outlining in detail the evidence-based
application of CEE. 17 The ASE recommended that CEE should be considered in the following clinical scenarios:
assessing left ventricular systolic function when quantitative volumes are required and during stress ecbocardiography
evaluating the left ventricular apex
evaluating mechanical complications of a myocardial infarction
evaluating a potential cardiac mass
evaluating perfusion (i .e. enhancing Doppler in the systemic circulation).
It should be noted that the above clinical scenarios are where CEE
may be considered, however, CEE should not be used routinely in these
scenarios. Rather, CEE should be used when non-CEE is not viable.
More specifically, CEE should be used if two contiguous left ventricular segments are not seen on non-contrast images. 17 Also of note, since
the publication of the consensus statement in 2008, the efficacy of the
recommendations bas been evaluated and found to be highly benefi cial
and safe in practice. 2 1 CEE may be particularly beneficial with obese
patients as image quality is usually poorer with non-CEE. 17

and enable the non-i nvasive ultrasonic imaging of this location . For example, inflammatory markers/receptors may be targeted to illuminate
the precise location. 23 In prec linica l models, microbubbles have been
targeted to inflammatory regions, atherosclerosis and cancer. 23 •24·25 Furthermore, this presents the potential to use microbubbles to specifically
target cells expressing certain receptors, allowing the deli very of drugs
or other materials to these specific cells. 26

Ultrasound-Mediated Gene and Dn1g Delivery
Using targeted or non-targeted microbubbles, drugs or genes may be
delivered to cells of interest. 26 Microbubbles are loaded with the drug
or gene of interest and upon imaging, high frequency ultrasound is deli vered to the area of interest to burst these bubbles and transiently create pores in the surrounding cells allowing for the intracellular delivery
of the microbubbles ' contents. 27 This technique is especially suited for
delivery to endothelial cell s as they are most easily accessible from the
blood stream where microbubbles predominate. Therefore, they can be
used to either destroy the endothelial cells (eg. eliminating the blood
suppl y to cancer cells) or promote angiogenesis in the case of vascular
disease (eg. promoting the growth of new blood vessels will increase the
perfusion of under perfused ti ssue due to occlusion). 28 •29

FUTURE DIRECTIONS

Centres are increasingly adopting CEE technology for the advantages it offers, especially as the safety of the procedure becomes realized. Clinical and research settings alike can benefit from the current
applications of CEE, and the many more promising avenues for its use
on the very near horizon .

New Applications in Assessing Myocardial Flow
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CEE is currently being used to assess myocardial perfusion, but
novel applications to its use are being considered. The first is bedside
CEE that could be used in emergency departments to aid in the workup of patients presenting with chest pain. Not only could this identify
higher risk patients and provide expedited treatment with the most appropriate modality, but it could obviate the need for other expensive or
invasive testing. 5 CEE could also be used in patients with recognized
ST elevation myocardial infarctions to gather valuable wall motion information for prognostic purposes. 18 Finally, the power of CEE for assessing perfusion has been recently used in new diagnostic situations
to evaluate patients with ischemic symptoms caused by vasoregulatory
mechanisms, as opposed to total obstruction of epicardial vessels. Thi s
is especially useful for gaining prognostic information in patients that
suffer from diabetes, hypertension, or dilated cardiomyopathy, and guiding therapy. 19
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Peripheral Vascular Imaging
The ability of CEE to accuratel y delineate ventricul ar borders has
been further applied to the identification of vascular borders. Recently,
CEE has been used to assess vascular disease due to its ability to evaluate the vasa vasorum, the system of vessels that penetrate and supply
blood to the walls oflarge vessels of the body. In atherosclerotic disease,
expansion of the vaso vasorum bas been shown to be integral in the
development of plaques, macrophage accumulation and plaque rupture.
2°CEE may play a future role in monitoring the development of the atherosclerosis, and stratifying patients for new therapies designed to slow
the later stages of the disease. 5

Targeted Microbubbles for Specific Imaging
Many novel applications derive from the molecular targeting of
microbubbles. Targeting molecules, such as ligands or monoclonal antibodies, may be conjugated to the surface of microbubbles. 22 These
targeting moieties may then bind to their target, localizing more microbubbles to the area of interest (where the receptor of interest is located)
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Bluewater Health
Sarnia & Petrolia, Ontario
Bluewater Health is recruiting for the following positions to provide services to the residents of
Sarnia-Lambton both in the community and at the hospital.
•
•
•
•

Cardiologist
Dermatologist
Paediatrician
Psychiatrist

•
•
•
•

Respirologist
Rheumatologist
Urologist
Family Physicians (Petrolia)- including low acuity Emergency

Bluewater Health is a 320 bed hospital operating on 2 sites which includes a recently completed
$319 million redevelopment. The hospital offers excellent medical and diagnostic supports:
·A broad range of diagnostic services, including CT and MRI.
• Full spectrum of specialists available 24/7 (neurosurgery not available)
Sarnia was rated the Most Livable City in Ontario by the Pembina Institute (August 2007). Situated on the
shores of Lake Huron at the border to Michigan, Sarnia offers excellent quality
of life, sports, arts and culture , education , state of the art health care
'
and beautiful natural environment
To inquire about these positions, please contact:
Dr. Mark Taylor, Interim Chief of Professional Staff
Bluewater Health
Medical_affairs@bluewaterhealth .ca
519-464-4400 ext 4534.

16

UWOMJ 181 :1 I Spring 2012

BLUEWATER
HEALTH
Life, health and renewal.

FEATURE ARTICLE

The new OACs are here ... don't forget warfarin just
yet!
Yin Hui (Meds 2015)
Faculty Reviewer: Dr. Michael J. Rieder, MD PhD FRCPC FAAP FRCP(Giasgow) (Departments of Paediatrics,
Physiology & Pharmacology and Medicine)

ardiac arrhythmias are health problems that become more common as people age, with atrial fibrillation (AF) being the most
common cardiac arrhythmia. AF can occur due to some diseases,
certain toxins, or as an adverse consequence of procedures that cause
pathophysiological changes. These in tum cause the electric signal in
the atria to be disturbed, which leads to rapid and irregular contractions.
Irregular heartbeats disturb the smooth laminar flow of blood, leading
to pooling of blood in the left atria. The conventional view is that this
stasis results in thrombi formation , mainly in the left atrial appendage. 1
These thrombi can travel to the left ventricle and be ejected to systemic
circulation, causing stroke when travelling to the brain, or systemic embolism when travelling elsewhere. The risk of stroke (per I 00 patient
years) can be predicted with a simple and validated CHADS 2 scoring
system (Table 1).2

C

The vitamin K antagonist, Warfarin, is the most common oral anticoagulant (OAC) used to prevent stroke or systemic embolism in patients
with AF. Warfarin works by inhibiting the production of clotting factors
II, Vll, IX, and X, and vitamin-K-dependent proteins C and S.4 The inhibition of these factors leads to a net effect of decreased thrombi formation, and 64% reduction in risk of stroke. However, this is accompanied
by an increase in risk for bleedings To minimize the risk of side effects
while maximizing efficacy, anticoagulation therapy must be monitored,
typically by measuring the International Normalized Ratio (fNR) on a
regular basis. The INR is an index of coagu lation, with a normal value of
0.8-1 .2. In most warfarin therapies, the target INR is 2.5, with an acceptable range of 2-3 . Regular INR testing can be cumbersome, especially
in the beginning of therapy, as patients need to have blood work done
to establish an optimal dosing, at first every 2-3 days, then every week,
and then every two weeks. Once an optimal maintenance dose is found ,
patients will continue to need INR measurements done every month for
monitoring.6
The loading and effective doses vary widely between patients taking Warfarin . This bas been attributed to a multitude of factors that affect the pharmacokinetics of the medication . Warfarin is 99.5% protein
bound, and therefore displacement by another highly protein bound drug
can greatly alter its bioavailability and effect. Metabolism of Warfarin
depends on several different enzymes, including the cytochromes 2C9,
2Cl9, and 3A4.6 These enzymes are responsible for metabolism of many
other commonly used medications, leading to drug-drug interactions.
Interactions also exist with many common ly used vitami ns and herbals .6
Common dietary foods contai ning vitamin K, as well as cranberry juice
and green tea, often will also affect the efficacy and safety of warfarin .7
Genetic polymorpbisms of the v itamin K receptor VKORC I and the cytochrome CYP2C9 make predicting the effective dose and establishing
maintenance dose even more difficult. 6 Routine genotyping to establish
dosing has been shown not to be cost effective, although the cost as-
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sumptions that this was based on may be dated .8 Finally, Warfarin has
a half-life of approximately 40 hours, leading to effects of changes in
dosing to be expressed several days later. Coupled with variabi li ty in
a person 's everyday life, it can be difficult to determine the causes of
changes in fNR. Difficulty in managing warfarin therapies have led to
patients being within the therapeutic INR range on ly - 50% of the time.9
In an attempt to overcome the challenges with Warfarin, both anticoagu lant and antiplatelet agents have been evaluated. In 2003 , ximelagatran (Exanta™, AstraZeneca) , a direct thrombin inhibitor, bas been
approved in some European countries for use in prevention of stroke and
systemic embo li sm for patients with AF, as well as for venous thromboembolism (VTE) after orthopaedic surgery. It was the first OAC marketed as a replacement for warfarin. 10 However, due to severe li ver toxicity discovered post-market, ximelagatran was withdrawn worldwide
in February 2006. 11 ln the ACTIVE-W trial , warfarin was compared to
combination therapy with acetylsali cylic acid (Aspirin™, Bayer) and
clopidegrel (Plavix™, Bristol-Myers Squibb and Sanofi-Aventis), with
Warfarin proved to be superior in efficacy and safety. 12 In the AMADEUS trial , Warfarin was compared to idraparinux (Sanofi-Aventis), a subcutaneous factor Xa inhibitor simi lar to fondaparinux , with idraparinux
having significantly more bleeding events. 13
More recently, several new OACs have been developed and brought
to market. Dabigatran (Pradax™, Boehringer lngelheim), a direct
thrombin inhibitor, ri varoxaban (Xarelto™ , Bayer), a factor Xa inhibitor, and apixaban (Eliquis™, Pfizer and Bristol-Myers Squibb), also a
factor Xa inhibitor, has already been shown to be effective in prevention
of VTE after orthopaedic surgery, joining the ranks of unfractionated
heparins and low molecular weight beparins. 14 ln 2009, the Randomized
Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial demonstrated dabigatran to be superior to Warfarin in prevention of stroke
and systemic embolism due to AF on the recommended dose of 150mg
twice daily, and non-inferior when using II Omg twice daily for elderly
patients or patients with reduced renal function. 15 Subsequentl y, the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with
Vitamin K Antagonism for Prevention of Stroke and Embolism Trial
in Atria l Fibrillation (ROCKET-AF) trial showed rivaroxaban to be
non-inferior to Warfarin in managing high-ri sk patients at 20mg daily. 16
Most recently, the completion of Apixaban for Reduction in Stroke and
Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
showed that apixaban was non-inferior to Warfarin at 5mg twice daily. 17
While each trial has weaknesses, there is a general trend of improved
efficacy and safety in their use.
These new OACs boast long awaited qualities: few drug interactions, virtually no dietary interactions, efficacy and safety not affected
by genetic polymorphisms, quick onset, short half-lives ensuring quick
offset, no need for laboratory monitoring, and improved safety profiles.
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Specifically, hemorrhagic stroke and serious bleeding bad statistically
18
significant risk reductions for all three agents. 15However, there are also proposed disadvantages associated w ith these
agents both individually and as a group. Dabigatra n caused potentiall y
15
severe heartburn or reflux in II % of patients in RE-LY. ROCKET-AF
had several major weaknesses in the trial design , leading to uncertaintie
about the true efficacy and treatment effect of rivaroxaban . Guidelines
have yet to be deve loped for apixaban in regards to switching to and
from warfarin, or holding for surgery at the time this article is written.
As a group, there are numerous down ides to the new OACs as well.
To begin with, Warfarin ha been used for the past 50-60 yea rs gathering
a large body of evidence and experience, whereas the new OACs come
with very few studies and little clinical experience. For example, there
is rea onably robust evidence for Warfarin u e in vu lnerable populations
such as pediatrics, whereas this population i routinely excluded in all
of the trials involving the new OACs. 19-21 In addition, many comorbidi ties were excluded by RE-LY, ROCKET-AF, and ARISTOLE, such a
valvular AF, creatinine clearance <30 mVmin, and active liver disease.
Given that the potential for significant adver e event in these excluded
populations cannot always be extrapolated from existing data, caution
should be taken in introducing new OACs to these patients.
Second, the new OACs have no reliable measurement of effect. The
sign of inefficacy is simply the occurrence or recurrence of stroke or
system ic embolism. On the other hand, Warfarin 's regular need fo r INR
monitoring can be beneficial. INR provides a urrogate marker of the efficacy of therapy. This allows Warfarin to be used in conditions exc luded
by RE-LY, ROCKET-AF, and ARISTOTLE, because there is a monitoring system available to adjust dose based on the INR.
Third, as Warfarin has been used for more than 50 years, its longterm efficacy and safety have been studied and we ll known . On the other
hand the "oldest" new OAC, dabigatran, just came onto market in 20 I 0.
Rivaroxaban and apixaban just concluded their landmark trials within
the past year. A long-term study of dabigatran, the RELY-ABLE trial
(NCT00808067), will evaluate its long-term efficacy and safety for a
maximum of just 28 months after first use. 22
Fourth , none of the new agents has corre ponding antidotes that have
been shown to predictably and reliably rever e their effects. In comparison , Warfarin has a reliable reversal agent in situations of overdo e/
toxicity - vitamin K, w ith established reversal guide lines.6 For the new
OACs, clinicians can use dialysis, fta h frozen pia rna, prothrombin
complex concentrates (PCC), or recombinant activated factor VII (rfVII) in situations of b leeding, although the efficacy of any of these approaches have not been demon trated .23 Experts have deve loped a set
of recommendations for treatment of anticoagulant associated bleeding
for the new OACs. However, these recommendation are often ba ed on
Criteria (one point each)

CHAD

c

Congestive Heart Failure

H

Hypertension

A

Score
2

an ecdotes and their efficacy remains theoretical. The lack of reliable
reversal agents, combined with the lack of evidence for use in patients
with poor rena l function, leads to uncertainty of use in frail, elderly pa25
tients, especially those of poor health .
Fifth, the short half-life of these new agents make them not fitted
for patients w ho are non-compliant (due to forgetfulness or otherwise).
These agents have half-lives less than 12 hours and reversible inhibitory
effects _IS- 17 Missing one dose could significantly affect circulating drug
levels and clotting factor inhibition, leading to changes in efficacy. However, no studies have been done to investigate this effect.
Finally, the new OACs cost up to $300/month, which is significantly
more expensive than Warfarin therapy and INR monitoring combined.26
The Ontario Drug Benefit plan has yet to add these medications to its
formulary for AF. Therefore, patients would have to pay out-of-pocket,
or use a third party payer, if therapy is desired. High cost of the medications may also pose a barrier in incorporation into the hospital formularies, since the cost would significantly affect the pharmacy budget.
In light of current information, the new oral anticoagulants are an
excellent alternative to Warfarin in certain situations. They offer highly
desired benefits of convenience and safety. In a non-valvular AF adult
patient who is often comp liant, with no active liver disease or severe
renal dysfunction, the new oral anticoagulants can offer a much better medication experience. o far, only dabigatran is approved on the
Canadian market for use in prevention of stroke and systemic embolism
in patients with AF. Se era! major teaching hospitals are looking at, or
have added dabigatran into their formularyY
As head-to-head trial between the new OACs will not be beneficial
for the parties involved, it is unlikely these trials will be conducted in
the near future . Therefore, when given a choice, clinicians should use
their clinical judgement to choo e the agent taking into account individual patient condition , as well a known afety and efficacy data of
each drug. A these new OACs are used and studied more often, clinical
experience and e idence may provide new facet of their use. With the
rapidly changing land cape, anticoagulation is certainly an area worth
watching. For now, don't forget about Warfarin just yet!
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The current role of focused assessment with
sonography for trauma {FAST) in the ever-evolving
approach to abdominal trauma
Brennan Ballantyne (Meds 2014), Alden Ling (Meds 2014), Alexander Pazion is (Meds 2015)
Faculty Reviewer: Dr. Roy W. Roebotham MD FCFP(EM) (Division of Emergency Medicine)
BACKGRO UND
Trauma i the leadin g cause of mortali ty worldwide, and is a leading
cause of death in both men and women under the age of 35 Y Apart
from the high incidence o f mortali ty, trauma is responsible for leaving
45 million people per yea r world wide with moderate to severe di sabilities. ' It is no surpri e that victims of traumatic events have ignifica ntl y
better morbid ity and mortality outcomes when treated at centres with
designated trauma units, where there are hea lth care professional that
have been trai ned in specific triage, di agnostic and treatment techniques
to manage trauma patients. 3
One of the main complicati ons leading to high mortali ty after trauma
is exsanguination from injuries to organs of the abdomen. The li ve r and
spleen are the most common culprits, with the kidneys inj ured often
as we ll. 4 Blunt abdominal trauma is most fre quently cau ed by motor
vehicle accidents involving both vehicle and pedestri ans. A minority of
other causes include blows or fa lls in volving the abdomen.5 The evaluation of abdominal trauma i one of the most challengi ng areas of acute
trauma management because injuries may not manifest in the initial assessment, phys ical fi ndings are often unreliable, the presence of other injuries causes d ifficult ies, and the patients can present with altered menta l
status from head injuries or intox ication. 6 Hi stori call y, blunt abdominal
trauma was even more difficult to manage becau e practitioner lacked
the non-invasive and expedi ent imaging techniques that are ava ilable
today. Non-therapeutic laparotomy was the primary meth od by whi ch
trauma personnel uncovered signi fica nt abdominal injury. However,
laparotomy carri e a ri sk of compli cation (0.8-2.3%) and ex po e the
patient to the short- and long- term sequelae o f the procedure. 7 There ha
been a continuous search for acc urate and ex pedient te ts that can detect
occult bleeding and obviate the need for inva ive procedure , uch a the
non-therapeutic laparotomy.

DIAGNOSTIC PERJTONEAL LAVAGE
The first report of the diagnostic peri toneal lavage (DPL) was in 1965 ,
and represented a maj or advance in the asse sment of abdominal injury.
The stud y was small , but it was abl e to diagnose hemoperitoneum in
I 00% of pati ents that presented with blunt abdominal tra uma .S ince
thi s initial in vesti gation, many studies have supported the result , and
there has been a gradu al increase in the use of DPL at trauma centres a
a repl acement for the non-therapeutic laparotomy. One such tud y by
Danne et. al. in 1988 found that onl y 0.25% o f patients were not correctl y di agnosed within 4 hours o f arri va l to the trauma centre, and fa lse
negati ve and positi ve rates were similarl y very low. Few complicati on
o f the procedure we re reported.9
The primary fun cti on o f DPL is to detect occult injuri es in hemodynami ca ll y unstable pati ents that have sustained either blunt or penetrating abdominal trauma, even with a low thresho ld of suspic ion. A second-
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ary fu nction a lso developed, name ly, to save unnecessary laparotomies. 10
The pri nciple of DLP is to infuse fluid into the peritoneum to mix with
possible intraperitoneal blood , and to recover the fluid through drainage.
A mall , midl ine inc ision is made in the sub-ing uinal region and the
linea a lba is separated. A peritoneal dia lys is catheter is inserted into the
peritoneum and he ld in pl ace by a purse string suture. Warm saline solution (0 .9% ) i then infu ed, drai ned and ent fo r ana lys is. Depend ing on
the ex perience of the phy ician , the entire procedure can take between
5 to 30 min utes . However, there are orne ignificant limitations to the
DPL.9 The procedure i invasive, it provides no inform ation regarding
the organ that is injured it has a high rate of negati ve laparotomies, and
it can be time con uming if the operator is unskilled. Therefore, newer
ultraso und-guided techni ques have largely ecl ip ed the DPL.

FOC SED ASSE SMENT WITH

ONOGRAPHY FOR TRAU-

MA
e ment for trauma patient became popular in
the early 1990 , addre ing the ho rt o mings of DPL. The technique
called Focu ed A e ment wit h onography for Trauma (FAST) was
fo und very early to be accurate, non-inva ive, and could provide expedient a id in the dec ision-maki ng process for furth er treatment in the
crit ica l care etti ng. FA T i a bed ide ultra ound a essment protocol
that can be perfo rmed rapid ly a a creening tool fo r the detection of
intraperi toneal injury and, le common ly, pericard ia! tamponade." The
a essment i not overl y complex, and can be performed by urgeons
and rad io logi t wit h equa l re liab ility. 12 C urrentl y, FAST is most often
u ed by urgeons and phy ician in the emergency department. Canadian ER practitioner ca ll the techn ique mergency Department Targeted
Ultra ound ( DTU) . 13
F T is perfo m1ed w ith the patient supine (if possible) and uses a
mobile ultra ound machine. The depth of ultraso und wave penetration
must be at lea t 20cm, so the tran ducer frequency that is usually required is 3.5-5MH z w ith a convex transducer. Several views are obtai ned of hi gh ri sk areas of the abdomen prone to fluid accumulation
afte r abdominal trauma. A lo ng itudina l view of the right upper quadrant
wil l allow vi ualization of the hepatorena l reces (Mori son 's pouch) that
can show free fluid after a li ver laceration . A long itudinal view of the left
upper quadrant to visuali ze the peri plenic pace will a ess for splenic
and renal injuries. Both transver e and long itudinal iews of the suprapubic region (pouch o f Doug las) are u ed to ru le out urinary bladder
ruptu re. Fina ll y, a Iran ve r e v iew of the subx iphoid region is ometimes
obta ined to as ess for free fluid of the peri cardium ." When perfo m1ed
by ex perienced sonographers, the entire exam wi ll take no longer than 5
minutes to complete. However, complication in obta ining the standard
v1ews can pro long the a sessment. 11
FAST i currentl y indicated to be used in the primary circulatory
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survey of an unstable patient that has sustained blunt abdomina l trauma
for detection of intraperitoneal and pericardia! fluid. A secondary indication of FAST is the assessment ofthe thoracic cavity to detect a possible pneumothorax. This protocol , termed extended FAST (E-FAST; or
EDTU-2 in the Canadian ER), is performed on unstable trauma patients
if there is time after the primary survey. This exam is based on the principle that air in the pleural cavity can be distinguished from air in the
lungs with ultrasound during normal ventilation . E-FAST has reported
sensitivities and specificities of 0.59-1.00 and 0.94-1.00, respectively. 11
It is currently unclear whether an E-FAST should be routinely conducted
in the critical care setting, but it is reasonable to conclude that if there is
sufficient time, an E-FAST can be performed to rule out pneumothoraces
before patients go to the CT suite or surgery.

ADVANTAGES AND LIMITATIONS OF FAST
The FAST protocol has many key advantages that make it superior to
DPL in the assessment of abdominal trauma. FAST boasts relative ease
of use, rapidity, availability, and low cost imaging. It offer greater flexibility for patient positioning, which is very important for patients who
have undergone significant trauma . It can be employed within minutes
of a patient's arrival at a critical care centre, while other health care personnel perform diagnostic and therapeutic maneuvers simu ltaneously. 14
A 2007 study found that patients with positive FAST results had significantly higher mortality than FAST-negative patients. FAST-positive
patients also had a higher likelihood of operation than FAST-negative
patients. Patients with equivocal FAST results, or areas that cou ld not be
well visualized, were found to have more statistically significant negative results and had a higher likelihood of operation than FAST-negative
patients.14 However, equivocal results only made up 6.7% of the assessments when FAST was undertaken by trained clinical sonographers. 15
These results highlight the importance of FAST as an effective method
for identifying patients at risk of serious intraabdominal injury. FAST
results can be used to guide mobilization of hospital resources, and identify patients who can be managed expectantly.14
However, limitations to the FAST technique do exist. Firstly, FAST
does not accurately detect the extent of, in some cases, the precise site
of organ injury. Therefore, FAST-positive patients often need to be fol-

lowed up with aCT scan to locate the origin of the bleeding and evaluate the extent of the injury.16 The sensitivity of FAST is also low (3455%) relative to other imaging modalities available. 17 Other limitations
of FAST are aspects that are inherent to ultrasound itself as an imaging
modality, such as operator dependence, inability to completely standardize the procedure, limited retroperitoneal accuracy, and poor scanning
results in obese patients or patients with tissue abnormalities like superficial wounds. 11

DEBATE ABOUT THE CURRENT ROLE OF FAST
There is considerable debate about what should be done in the case of
negative FAST results for hemoperitoneum . Some studies show as many
as 29% of negative scans still have some degree of intraabdominal injury.18 Since CT scanning has become more widely available, faster, and
a more econom ical test than it was in the past, it has come to dominate
much of the survey of abdominal trauma patients. CT is a more accurate
test than FAST, especially when comparing the false negative rates of
both tests. The discordance in the results of CT and FAST have Jed to
some centres adopting the CT scan as the primary imaging modality for
blunt abdominal trauma .18 However, the utility of FAST is only questionable when it is used as a purely diagnostic tool. Recent evidence
suggests that clinical suspicion shou ld sti ll play an important role in determining the therapeutic steps for trauma patients. For examp le, if a patient sustained a seatbelt injury, a negative FAST result cou ld probably
still be followed with aCT scan to ensure that no intraabdominal injury
exists .19·20 A stand-alone FAST result shou ld not preclude patients from
further investigation, or guide treatment by itself. It is in this setting that
the value of FAST is realized. As a screening tool implemented in the
primary circulatory survey, along with avai lab le clinical evidence, FAST
is instrumental in the first decision point for trauma patients: to the OR
or further investigation? 14 Figure I depicts a typical decision tree, where
FAST is integral to the early steps. In this role, FAST-positive patients
can be dealt with in the most expedited manner possible, and patients
with negative or equi voca l results can undergo further testing. This approach still results in effectively identifying the maximum number of
at-risk patients, while using CT scanning sparingly. This saves the hospital money, frees up valuable CT suite time, and avoids unnecessary
radiation exposure to patients. Overall , FAST can be viewed not as a
Intervention
Yes

No
Observation

BLUNT ABDOMINAL INJURY
CT Scan (follow CT path)

Observation

Figure 1. The typical decision-making process involved in the assessment of blunt abdomina l injury. Adapted from van der Viles et. aJ.2'
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solitary solution to a diagnostic problem, but as an adj unct to the triage and decision-making process. In this capacity, there will still be a
very integral role for FAST in the work-up of blunt abdominal trauma
patients for the foreseeable future.
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INTRODUCTION
For the past 40 years, the use of biomarkers has been extremely valuable
in the early diagnosis of acute myocardial infarctions (AMI). Sens itivity, specificity and the clinical utility have continued to increase and
current research suggests that this trend will continue. This article wi ll
review the use of previous and current AMI markers and will conclude
with a review of promising new markers.

AMI BIOMARKER PROTOCOL
To detect MI markers, venous blood is routinely drawn from patients
with chest pain who are suspected of having symptoms of acute coronary syndrome (ACS). 1 The marker of interest is presumed to be released from the cardiac tissue which is under ischemic stress and thus
may be detected in the blood sample.2 A detected elevation in a particular marker may lead to early diagnosis and treatment and thus improved
patient outcomes. 1
Characteristics of biomarkers centre around three main elements,
namely, kinetics of release, specificity and sensitivity. 3 An ideal marker
of cardiac necrosis should exhibit the following characteristics: cardiac
specificity, early and stable release after necrosis, predictable clearance,
and be measurable quantitatively using rapid, cost effective methodo logies available in the majority of clinical laboratories.4

PAST AND PRESENT AMI BIOMARKERS

tissue while CK-BB is found in brain tissue and CK-MM is in skeletal
and cardiac tissue. 8 Furthermore, release of CK-MB on ly occurs upon
death of myocardial cells and it is not released in the setting of ischemia .9 Therefore, CK-MB was considered to be the most useful biomarker for detecting myocardial injury. Kinetic studies have shown that
CK-MB is detectable 4-8 hours after the first onset of chest pain and
peaks at 18-24 hours post MI. 8· 9 However, the CK-MB Immunoassay
lacks absolute specificity, is absent in minor myocardial infarctions, and
has poor prognostic value in ACS patients. Despite these weaknesses it
is currently a routine part of the cardiac work-up.
In the 1970s and 1980s, CK-MB transformed the diagnosis and treatment of patients with acute cardiac events. CK-MB proved even more
specific than an accurate clinica l history, which is often unattainable in
the critically ill or is atypical in the elderl y and diabetics. CK-MB was
more reliable than EKG pattern recognition which can be blind to disease depending on the location of the ischemia. CK-MB also improved
specificity over myoglobin (90% vs 70% specificity, respectively) and
consequently became the gold standard for identification of cardiac injury. In the absence of myocardial infarction, CK-MB may be elevated due
to poor specificity in patients who present with multiple co-morbidities
or conditions including renal failure, non-cardiac surgery, chest trauma,
asthma, pulmonary embo li sm, chronic and acute muscle disease, bead
trauma, hyperventi latio n, and hypothyroidism. 10• 11

Troponin

Myoglobin
Myoglobin is a heme protein found in almost all muscle types and is
especially high in cardiac and skeletal muscle.5 Quantitative immunoassays are currently available. This marker 's strength is its high and early
sensitivity post-MI. The marker 's obvious weakness is the low specificity due to the presence of high level s of myoglobin in skeleta l muscle .5
Therefore, myoglobin is suggested not to be used on its own but on ly in
the context of other markers, EKGs and clinical evaluation .

Lactate Dehydrogenase
Lactate Dehydrogenase (LD) is an enzyme involved in anaerobic metabolism, reversibly converting pyruvate to lactate. 6 LD is fairly ubiquitous; however, one of the five isoenzymes, LD I, is highest in cardiac tissue. LDI is elevated post-MI and the LDI :LD2 ratio when greater than
1.0 is diagnostic of an AMI. LD I elevation and LD I :LD2 ratio changes
are detectable 8-12 hours post Ml and peak at 24-72 hours.7

Creatine Kinase
Creatine Kinase (CK) is an enzyme found in high amounts in muscle
tissue due to its role in muscle contraction .8 CK has two subunits, M
and B, which are combined to form three isoenzymes: CK-BB (CK-1 ),
CK-MB (CK-2) and CK-MM (CK-3). 8 CK-MB is specific to cardiac

While troponin proteins are present in both cardiac and skeletal muscle, the cardiac isoforms of troponin T and I are highly specific to the
myocardium . Assays using specific antibodies against cardiac troponin
Tor I allow measurement oftroponin release from the myocardium .4 In
2000, the European Society of Cardiology (ESC) and American College of Cardiology (ACC) task force concluded that diagnosis of AMI
required biochemical evidence of necrosis and indicated the marker of
choice as troponin . 12
The increased sensitivity of cardiac troponin over CK-MB is primarily due to the fact that the percentage oftroponin released into the blood
after an acute cardiac event is greater for troponin than CK-MB. Troponin concentrations rise quickly after the onset of chest discomfort. Thus,
in upwards of80% of patients, a definitive diagnosis can be made within
6 hours from the onset of chest pain . Furthermore, peak concentration
of CK and troponin give a reasonable estimate of infarct size. More recently, novel prototype cardiac troponin assays have been developed
that are up to 10-fold more sensitive than the currently used assay and
yie ld prognostic value on potentia l future Mls. 13 · 14 For comparison of
troponin and other available markers please see Table I.
Troponin has become the biochemical marker of choice for the detection of cardiac injury. But still lacks sensitivity within the first hour
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Troponin
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15

of an AM 1. Furthermore, clinical guide lines still di ctate that Troponin
results should be interpreted wi th clinica l findin gs and EKG results and
not in isolation. 16

FUTURE MARKERS
While current markers have greatl y improved the diagnosi and qui ckened the treatment of AMI patients, there is still room for improvement,
especia ll y in the area of earl y detection.3 The fo llowing markers are
some of the potential MI markers of tomorrow that may improve seniti vity, specificity, prognostication and decrease time between (or even
predi ct) chest pain onset and diagnosi /treatment.

Myeloperoxidase
Myeloperox ida e (MPO) is a haemoprote in produced by po lymorphonuclear neutropbils (PMN) and macrophages. It converts chloride
and hydrogen perox ide to hypochlorite which i re lea ed durin g infl ammati on and is in volved in lipid oxidation that is conta ined in LDL particles. Thi s process promotes fo rmation of foa m cell in atherosclerosis. MPO is a marker of pl aque instabili ty and there fore presents a a
potentia l strong prognostic marker o f an MI in the near future. MPO i
lowest in patients wi th stable coronary artery disease, hi gher in patients
with unstable angina, and highest in patients with AMI. 17

Copeptin
Copeptin is the C-terminal fragment of the vaso pressin precursor
horm one whi ch i released in response to low blood pressure. A lso, the
measurement of copeptin has been shown to have very strong negati ve
predi cti ve value, along with troponin , fo r AMI. 18 Additi onall y, co peptin
levels are elevated earl y after AM I and are detectable in patient who
present soon after symptom on et whil e troponin is still negati ve. 19

Growth differentiation factor 15
Growth di ffere ntiati on fac tor 15 (G DF- 15) i a tra nsform ing growth
factor. Cardi omyocytes ex press and ecrete G DF- 15 in the setting of
ischemia and reperfusion, suggesti ng that it might be a protective factor. As well , GDF- 15 bas been identified in acti vated macroph age , and
a di stinct up-regu lation has been found in many tis ue fo llowing inj ury,
ischemia, and other fo rms of stress.20

Heart-type fa tty acid-binding protein (H-FA BP)
H-FAB main advantage is that it is re lea ed soon after cardiac inj ury and thus may be a great potentia l improvement fro m myog lobin
as an earl y bi omarker. The ma in di advantage i that it is not exc lu ive
to heart (a lso is fo und in skeleta l muscle - although in much smaller
amounts).21 Add iti onall y, it is useful in di stinguishing ri sk even in patients without elevated BNP or Troponin .22

8 -type natriuretic peptide (BNP) and N- Terminal fragm ent of pro-BNP
(NT-proBNP)
BNP i a neurohormone re leased from cardiac cell s fo llow ing ve rtica l wa ll stress and myocyte stretching. 22 Both the active form BNP,
and the inactivated N-Term inal peptide " NT- proBN P" can be mea-

sured as markers o f hemodynamic stress). Whil e investigations have
shown that e levated BNP and NTpro BNP levels are predictive of death
and heart fai lure they are not use fu l as indicators of new or recurrent
AMJ.23.2 4 More research is bei ng conducted to estab lish the use of these
biomarkers for selectin g treatment of acute coronary syndromes.22

high sensitivity C-reactive protein (hsCRP)
C-reactive prote in is a marker of inflammation and may be part of
the mechani sm of atherosclerotic plaque produ cing thrombus. Elevated
leve ls are predi cti ve of death and heart fa ilure post MI. hsC RP is nonspecific fo r card iac inflammatio n; however, measurements of forms specific to vascular inflamma tion are being developed and may be more
pecifi c fo r AMl 25

placental growth factor (PIGF)
P IGF is also a useful indi cator of pl aque instabili ty - more specifica lly - may be a determ inant/ca use of plaque instability and thus is a
potential drug target to prevent AM J.2 6

WBCHO and p lasma choline (PLCHO)
Whole blood cho line (WBC HO) incl ude measurement o f cho line in
hemo lysed erythrocytes. Cho line leaks fro m ischemic tissues into plasma. In pia rna, it is eventuall y taken up by blood cell (hence the di ffe rentiati on between these two measurements). Both w ho le blood cho line
and plas ma choline level are of u e fo r predi cting cardiac ischemia in
patient with negative troponin. T he use of who le blood cho line may
also extend to determ ining plaque stabili ty. Thus, the e markers might
be of u e fo r predi ctin g myocardi al infarct (detection pre-necro is)Y

CONCLUSI ONS
Over the past several decades, the use of cardiac bio markers has
greatl y improved the diagno is of AMI . As more markers have
emerged, en itiv ity and pecificty has increased and time to diagnoi and treatment ha decrea ed. Currentl y, the be t marker available in clinical practice i troponin ; however even troponin results
hould be interpreted within a clinica l context and not used in iso lation. Furthermore, there i still room for improvement and current research seem to suggest there are more marker sti ll to come
whi ch w ill improve AM I diagno tics, prognostics and predi ction .

REFERENCES
I. ~orrow DA. Chapter in: ardi ovascular biomarkers : pathophysiology and
d1sease management. Huma na Pres , c2006.
2. Yiadom MY. Acute coronary yndrome clinica l presentati on and diagnosti c ap proaches 111 the emergency department. Emerg Med Clin North Am
20 11 ;29(4):689-97.
3. Chri stenson RH , Azzazy HM E. Biomarkers of myocardi al necro is: pa t,
present, and future: 3-25.
4. Saenger A. A ta le of two biomarker : the use of troponin and CK-MB in contemporary practi ce. C/in Lab Sci 20 I0;23(3): 134-40.
5. Rajappa M, Sharma A. Biomarkers of cardi ac inj ury: an update. Ang

24

UWOMJ I 81 :1 I Spring 2012

DIAGNOSTIC REVIEW
2005;56(6):677-91 .

plasma choline in acute coronary syndromes: prognostic and pathophysiological implications. Clin Chim Acta 2007;383(1-2): I 03.

6. Wu AHB. Cardiac Markers. Humana Press, 2003 .
7. Leung FY, Handerson AR. Thin-layer agarose electrophoresis of lactate dehydrogenase isozymes in serum: a note on the method of reporting and on the
lactate dehydrogenase isoenzyme-! /isoenzyme-2 ratio in acute myocardial
infarction. Clin Chem 1979;25:209-211.
8. Bloomberg DJ, Kimber WD, Burke MD. Creatine kinase isoenzymes. Predictive value in the early diagnosis of acute myocardial infarction . Am J Med
1975;59:464-469.
9. Ishikawa Y, Saffitz JE, Meal man TL, et at. Reversible myocardial ischemic
injury is not associated with increased creatine kinase activity in plasma. Clin
Chem 1997;43:467-75 .
I 0. Jaffe AS. Biochemical detection of acute myocardial infarction. In : Gersh
B, Rahimtoola S, eds. Acute Myocardial Infarction, Elsevier, 1991 : I I 0-27 .
II. Wu AH, Wang XM, Gomet TG, Ordonez-Llanos J. Creatine kinase MB isoforms in patients with skeletal muscle injury: ramifications for early detection
of acute myocardial infarction. Clin Chern 1992;38:2396-400.
12. Priori SG, Aliot E, Ble mstrom-Lundqvist C, et at. Task foce on sudden cardiac death, European Society of Cadiology. Europace 2002 Jan;4( I ):3-18.
13. Hochholzer W, Morrow DA, Giugliano RP. Novel biomarkers in cardiovascular disease. Am Heart 12010; 160(4):583-594.
14. Bonaca M, Scirica B, Sabatine M, et at. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for
cardiac troponin I. JAm Col/ Cardio/2010;55 :2118- 2124.
15. Morrow DA, Cannon CP, Jesse RL, et at. National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics
and utilization of biochemical markers in acute coronary syndromes. Circulation 2007; 115 :356-75.
16. Karras DJ, Kane DL. Serum markers in the emergency department diagnosis
of acute myocardial infarction. Emerg Med Clin North Am 2001 ; 19(2):321-37
17. Eggers KM , Dellborg M, Johnston N et al. Myeloperoxidase is not useful
for the early assessment of patients with chest pain. C/in Biochem 2009;
43(3):240-5 .
18. Yoors AA, von Haehling S, Anker SD, et at. C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an
acute myocardial infarction: results from the OPT!MAAL study. Eur Heart J
2009;30: 1187- 1194.

With expert hands and creative minds
it's our mission at PRHC to provide
exceptional care for our patients.

19. Reichlin T, et at. Incremental value of copeptin for rapid rule out of acute
myocardial. JAm Col/ Cardia/ 2009;54(1):60-8.

PRHmC

Peterborough Regional
Health Centre

20. Shi Y, Massague J. Mechanisms ofTGF-beta signali ng from cell membrane
to the nucleus. Ce//2003 ; 113:685- 700.
21 . Morrow DA . Biomarkers of myocardial necrosi s: past, present, and futu re.
Humana Press, c2006 :3-25 .
22. Wood FO, de Lemos JA. Sorting through new biomarkers. Curr Cardia/ Rep
2008; I 0(4):319-26.
23. Mi:ickel M, Danne 0 , Mu ller R, Yol lert JO, et at. Development of an optimized multi marker strategy for early risk assessment of patients with acute
coronary syndromes. C/in Chim Acta 2008;393(2): I 03 .
24. Morrow DA, et at. Evaluation of B-Type natriuretic peptide for risk assessment in unstable angina/non- ST-elevation myocardial infarction : B-Type
natriuretic peptide and prognosis in TACTICS-TIM! 18. JAm Col/ Cardia/
2003 ;41 (8): 1264-72.
25 . Chan D, Ng LL. Biomarkers in acute myocardial infarction . BMC Med
20 I 0;8( I ):34.
26. Apple FS, Wu AH, Mair J, Ravkilde J, et at. Future biomarkers for detection of ischemia and risk stratification inacute coronary syndrome. Clin Chern
2005;51 (5):81 0 - 824.
27. Danne 0 , Lueders C, Storm C, Frei U, Mockel M. Whole blood choline and

UWOMJ 181:1 I Spring 2012

25

ETHICS AND LAW

Application for psychiatric assessment (form 1) in
the ER setting: detainment without a trial
Niran Argintaru (Meds 2014) and Jon Fairbairn (Meds 2014)
Faculty reviewer: Dr. Abraham Rudn ick BMedSc, MD , MPsych , PhD , CPRP, FRCPC (Departments of Psychiatry and Philosophy)

,
J

a 36 year old mother of two is brought into the emergency department by police fo llowing her neighbours' complaints of violent
threats made by her towards them. J bas a history of manic depressive episodes but has never acted violentl y or displayed homicidal ideation. The attending emergency physician examines 1 and notes that she
bas recentl y demonstrated recurrent episodes of unexplained aggression
towards fa mil y members. The physician is concerned that this presentation represents a worsening of J's psychiatric illness, and that she could
present a risk to herself, her family or her neighbours.

The application for psychiatric assessment (APA), also known as a
Form I in Ontario, is a widely used tool available to phys icians who
have a "reasonable cause" to believe a person should be mandated to
undergo a psychiatric evaluation in an in-patient setting. Here we review
the circumstances under whi ch a Form I can be applied, highl ighting the
legal basis and focusing on its use in the emergency department. We also
outline the patient 's rights when a Form I is applied to them, as well as
the consequences for the patient and the responsibility of the signing
physician as outlined under sections 15, 18 and 20 of the Ontario Mental
Health Act. ' In addition, we will discuss some of the ethical and legal
imp lications of Form I use.

THE LEGAL BASIS OF FORM 1 USE
A Form I can be applied when a licensed physician believes that the
patient has either threatened or attempted harm towards themselves or
others through action or neglect due to psychi atric causes . Note that fo r
non-psychi atri c medica l causes, such as brain injury re ulting in cogniti ve impairment, a patient can be detained without a Form I. A lthough
the signi ng physician must personally examine the patient within seven
days prior to a Form I being signed, any phys ician can perfo rm the sa id
exam under secti ons 15. 1 and 15.2 of the Ontari o Mental Hea lth Act
(OMHA). A poli ce offi cer who has suspicions si milar to those outlined
above may ta ke a person into custody under section 16 of the OMHA,
but must fac il itate an eva luation by a phys ician as soon as rea onably
possible, and the physicia n may then fi ll a Form I. In the event that the
patient is in the communi ty when a Form I is signed, deli very of the
patient to a fac il ity with psychi atric in-pati ent serv ice (also kn own a
a schedu le I fac ility) can be fac ilitated by anyo ne, citi zen or law enfo rcement official, within the seven day expiration peri od. In London,
schedule I fac ilities incl ude: Victori a Hospi ta l, Un iversity Hospital, St
Joseph 's Hea lth Care and Regional Mental Health Care - St Joseph 's. 2

FORM I USE AND ITS OUTCOMES
On a Fonn I, the physician must outline the findin gs that have contributed to suspicion of a mental disorder, including fac ts that were reported
by collatera l sources such as the police or fa mil y members (section
15.3). 1 Upon the completi on of a Form I, the pati ent can be held without
consent in hospital fo r up to 72 hours in order to fac ilitate a complete
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evaluation (section 15.4). On a Form I , the physician must select either
"Box A - Serious Harm Test" or " Box B - Patients Who are Incapable of
Consenting to Treatment and M eet Specified Criteria".3 Box A focuses
on past, present and future ri sks or threats of harm to themselves or
others. If Box A is used, the patient can be held for exam as described
above, but treatment cannot be provided without consent. Box B on the
other hand is used for patients who meet the foll owing criteria: I) they
have an establ ished mental diagnosis that has improved with treatment,
2) without treatment they are incapable of consenting to treatment (recognizing that wi th treatment they may or may not be incapable of consenting to the treatment), and 3) they pose a risk to themselves or others.
By compl eting Box B, the physician affirm s that under the Health Care
Consent Act, the patient is incapable of consenting to treatment and a
substitute decision-maker w ill be consulted (in relation to the relevant
psychiatric treatment). It is wo rth noting that due to the fa ct that Box B
requires considerable background know ledge about the patient, its use in
the emergency department is rare. The vast majori ty of Form I applications by non-psychi atric physicians are made using "Box A".
In addi tion to a Form I, the physician must also complete and provide the patient with a Form 42, whi ch is a noti ce to APA, meant to
info rm the patient that be or she is being held in hospital and the reasons
for this decision. A Form 42 outlines the patient's right to contact a lawyer without delay and the responsibili ty of the hospital to aid that contact. The Act does not mandate that the physician read the patient their
ri ghts or noti fy a rights advisor about the involuntary detainment under
a Form I (a rights advisor is legally required to be notified by the phys ician fo r in lances of involuntary admission as with a Form 3 and a Form
4 per the OMHA). However, the phys ician should inform the patient of
the current therapeutic plan and that the patient will remain in hospital
un ti l a p ychiatric assessment can take place by a certified p ychiatrist.
In contra t to an invo luntary admission decision under section 20 of the
O MHA, a patient on a Form I does not have the right to appeal a Form
I decision to the Consent and Capacity Board.
Following the 72 hour evaluation period, there are three possible outcomes to Form I use: the patient can be released, the patient can be admitted voluntaril y under section 12 of the OMHA, or the patient can be
invo luntari ly admi tted to a schedu le I fac ility follow ing the completion
of a Fo rm 3 by a physician under ection 20. 1. 1 of the OMHA. 1 Note
that if a decision is made to invo luntarily admit, the admitting physician
cannot be the same one who completed the Fonn 1.4

FORM I USE AND MEDI CO-LEGAL CONS IDERATIONS
We found n? precedent of a physician having successfu l legal action
brought aga mst them fo r the use of a Form I . Thi s may be due to the
fac t that patients cannot appeal the app lication of a Fonn 1 and that the
sho rt duration of a Form I can be considered to result in ~nly a minor
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Form 1: Application for Psychiatric Assessment (ASA)

on the experience and comfort level of the physician with identifying
risk factors and dealing with high risk psychiatric situations.

Completed when a physician believes that due to a mental
health condition, a patient:
•
Has attempted harm to others or themselves
•
Has threatened harm to others or themselves
•
Is unable to care for themselves

Hence, to use a Form I, the patient must not be an appropriate voluntary candidate. Thi s is decided on the basis of weighing the complex
interplay of social, psychological and medical variables in the patient 's
life. To some degree this assessment may be influenced by the ER physician's experience and the practical demands of running a busy ER department.

Rights of the patient:
•
To be immediately given a Form 42 outlining the
reasons for being held in hospital
•
To be assessed for a period of no more than 72
hours, during which they receive a formal psychiatric
evaluation
•
To contact a lawyer without delay
Responsibility of the physician and hospital:
•
Facilitate the patient's rights outlined above.
•
To not provide treatment without informed consent
under Box A.
•
Explain the patient's rights and situation .
Results
•
•
•

of a Form 1 after no more than 72 hours:
Patient is released back into community
Patient is admitted voluntarily
Patient is admitted involuntarily upon completion of a
Form 3

A Form 1 expires 7 days after being signed. A physician
can only sign a Form 1 if they have personally examined
the patient.
A Form 1 can be found at: http://www.health.gov.on.ca/en/
public/forms/mental_fm.aspx
Figure 1: Quick guide to Form I

restriction of freedom and hence of minor legal importance. Referring
to limiting physicians' liability in cases of involuntary detainment of
longer duration, the Canadian Medical Protective Association recommends that physicians continue to exercise their judgement and opinion
honestly and in the best interest of the patient and others. 5 Thi s recommendation could be applied equally well to the application of the Form
I, even ifthere is no legal precedent of actual liability in these cases.
THE INVOLUNTARY PATIENT

In the event that there is reasonable cause to suspect that a patient may
cause harm to themselves or others in the near future, such as in J's case,
an ER physician will likely wish for the patient to undergo a psychiatric
assessment (PA). Importantly, this may occur voluntarily or involuntarily if the physician deems it necessary. A Form I is only required for
involuntary detainment of a patient.
In order to be an acceptable voluntary candidate, the physician must
be reasonably confident that the patient will comply with instructions
and is unlikely to cause harm . This assessment includes the consideration of several factors, such as suicide, harm to others, self-harm and
self-care. Further, the severity and intensity of ri sk-related thoughts, formulation of dangerous plans, access to lethal means, level and competency of supervision and willingness to contract for safety (an agreement
the patient makes to seek help before acting on self-harm or aggressive
impulses) are important factors to consider. In addition, the patient's
support system is an important factor and the absence or withdrawal
of this support may be a deciding factor for the patient's involuntary
detainment. 6 lt is important to note that meeting the above criteria hinges

GROUNDS FOR PATIENT DETAINMENT

The decision to involuntarily detain a patient balances the restriction of
a patient 's liberty and the need to safeguard the patient and/or society.
This may result in stigma or emotiona l trauma to the patient from the
restriction of freedom . This is a significant social and moral matter, considering there are only a handfu l of circumstances in which our society
permits such restrictions against an individual , such as during crim inal
proceedings.
The implied rationale for detainment is that the short-term cost to the
individual is acceptable to society at large to help prevent future harm .
This is a significant matter considering that a patient may be detained
even if they have not performed any harmful actions, such as in J's case.
The pati ent may merely be suspected with reasonable cau e by the physician to be likely to carry out harmful actions in the near future. Indeed,
the criteria for Form I use are broad and non-specific, and can be applied
to many patients, sometimes even in situations where the necessity of
the use of a Form I is debatable. This large amount of power given to
physicians in the legi slation can serve the patient and society well if applied judiciously. Conversely, if it is applied in a less than conscientious
manner, there is potential for abuse or negligence.
Additionally, there are inequalities relating to the time frame of the Form
I. For example, in a major urban centre where psychiatric care is readily
available, the patient will often receive a psychiatric assessment within
several hours of medical clearance and will not have to be admitted into
hospital. However, in underserviced regions, access to a psychiatric assessment may be difficult and the patient may be admitted to a nonpsychiatric facility (a non-schedule I facility) while he or she awaits a
psychiatric assessment. 6 In fact, under the law there is no limitation to
the repeated use of Form I to detain patients for longer than 72 hours.
In the above-noted case, J was detained under a Form I and was released following a psychiatric assessment and the completion of a treatment plan. Still, in some cases, patients who are detained involuntarily
incur an individual cost, in spite of the legally-based assumption that
this will protect society or themselves. The decision to utilize a Form
I should not come lightly and must adhere to all the requirements outlined here. A Form I entrusts physicians with significant powers based
on the legislature's trust that they will abide by stringent principles in the
decision-making process.
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Medical and economic benefits of chest pain units
in the diagnosis and treatment of acute coronary
syndrome
Tommy Choy (Meds 2015), Jessica Jackson (Meds 2015)
Faculty Reviewer: Dr. Lois Champion , M.D., FRCPC, Department of Anesthesia/ICU
ACUTE CORONARY SYNDROME
Acute Coronary Syndrome (ACS) is a general term used to describe a
spectrum of life-threatening conditions affecting the heart and circulation. In ACS the heart's blood supply becomes suddenly restricted by
the formation of a thrombus in the coronary arteries. Depending on the
severity of the blood clot, a spectrum of heart conditions can occur. This
spectrum ranges from minor chest pain (angina) to major cardiac events
including myocardial infarctions.'
A number of risk factors are associated with the development of
ACS . These include smoking, obesity, hypertension, diabetes, dyslipidemia and aging. As the prevalence of these risk factors increase within
Canadian society, the societal cost of ACS continues to increase.'

DIRECT MEDICAL COSTS OF ACS
Affecting approximately I 00,000 Canadians each year, ACS is currently
the second leading cause of death in Canada. In 2008-2009, there were
109,109 hospitalizations due to ACS and over 21 ,000 deaths.' Although
a large proportion of deaths from ACS occur before the patient reaches
the hospital, emergency rooms are the primary sources of treatment for
Canadians presenting with ACS .2
A combination of numerous factors, including severity of the ACS
event, hospital resources, and local clinical practice determine the total
direct medical cost of ACS . With these variances in mind, the national
average hospitalization cost for a heart attack in 2008-2009 was found
to be approximately I 0,000 dollars and the national average for treating
acute chest pain was approximately 4,500 dollars. Representing a total
annual direct cost of over 1.5 million dollars each year, ACS is clearly a
large burden on Canada's finite medical resources. '

ECONOMIC COSTS
In addition to the direct medical costs outlined above, ACS al so represents a significant burden on Canada 's economy. Producti vity losses
in the form of premature retirement, increased sick leave and death of
qualified workers all contribute to a decrease in national Gross Domestic
Product. ACS is responsible for 1.3 days of sick leave per year contributing a cost of 1.8 billion to the Canadian economy in 2008-2009.'
Representing approximately 0.12% of the 2009 gross domestic product
of Canada this economic cost is clearly placing a significant burden on
Canada's economy.'

CURRENT TREATMENTSTR UCTURES
Depending on the severity of a patient's presentation, numerous diagnostic and medical procedures are performed in hospital to treat each
patient presenting with ACS . ACS is currently treated using procedures,
lab tests, risk stratification and recommendations about lifestyle changes depending on each patient's presentation. Different centers across

Canada have unique procedures for ACS triage and treatment. 3 The individualized method common to most emergency rooms has however
been fo und to be only 73 .8% sensitive for detecting cases of ACS. In
fact, Christenson et al. found that the average Canadian emergency room
misses 5.3% of ACS cases and that considerable heath care resources
are expended on inefficient diagnostic and treatment procedures.3 This
article discusses the medical and economic benefits of a new form of
ACS triage - Chest Pain Units .

CHEST PAIN UNITS (CPU)
Numerous methods have been developed over the years in response
to the unsatisfactory diagnostic quality of Acute Coronary Syndrome
(ACS) identification in emergency departments. The chest pain evaluation unit, or chest pain unit (CPU), is an area within the hospital or the
emergency department itself that is used to reduce inadvertent discharge
of patients with low to moderate risk of ACS . While many different protocols are adopted across hospitals, CPUs try to identify acute myocardial necrosis, rest ischemia, and exercise-induced ischemia 4
Within the CPU, patients are assessed using past history, risk factor
identification, physical examination, serial ECGs and serial evaluation
of cardiac biomarkers. Patients are usually kept in the unit for a minimum of 6 hours and may be observed for as long as 18 hours, depending
on the test results . Patients with positive test results for serial markers,
such as the level of high sensitivity troponin, are admitted to the hospital
for further evaluation .5 Those with a negative result may be referred for
further testing, such as graded exercise testing, stress nuc lear imaging or
stress echocard iography.4

COST EFFECTIVENESS
In the United Kingdom and United States, many studies have been done
to examine the cost effectiveness of chest pain units. In these studies,
costs included both direct and indirect medical costs, and the effect measured is the quality adjusted life year (QALY) gained.6• 7• 8 From an economic viewpoint, a cost effective intervention should provide positive
incremental value. Within this, interventions that provide an increased
benefit at a lower cost are considered dominant and should be adopted;
whi le an incrementa l cost effectiveness ratio (difference in costs/difference in effects) shou ld be calculated for treatments that are more expensive.
In the past decade, many single center studies were done in the USA
that compared the use ofCPUs with hospital admission for patients with
low to moderate risk of ACS . These studies all found the CPUs to be
more cost effective than hospital admission . More recently, studies were
done that compared the use ofCPUs with standard care based on the expertise of the emergency department staff. These studies are more likely
to estimate real differences due to the fact that not all patients receiv-
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ing care become inpatients. In one single center study conducted in the
UK, it was found that CPUs reduced the number of admissions to the
hospital and improved health utility. 7 CPUs were also associated with
an increased cost of2,750 pounds (or 4300 dollars) per QALY gained,
but this was well within the value of 20,000-30,000 pounds per QALY
recommended by the National Institute of Clinical Excellence. Overall,
the study estimated a 95% probability that CPU will be cost effective.7

Currently, there is no single optimal evaluation protocol across hospitals
that can accommodate for the differences in local resources and expertise. In addition, there is insufficient evidence to advocate for the formal
implementation of chest pain units in Canada. Further research in this
area is recommended in order to improve the outcome of patients with
suspected ACS.

Subsequent multicentre studies in the UK, however, were unable to
reproduce the findings . The Effectiveness and Safety of Chest Pain Assessment to Prevent Emergency Admissions trial showed that CPU care
did not reduce the number of patients admitted and may even increase
admission from emergency and other routes.6 Another study investigated whether or not CPU care may be cost effective by improving health
outcome and reducing cost in other ways. The study did not find any
significant differences in health outcome between CPU care and routine
care and onl y estimated a 70% probability of CPU being cost effective.6
These studies are subject to many uncertainties and more research is
recommended to a certain whether or not the immense capital required
for implementing CPU care is justified.

I. Charles River Associates. The burden of acute coronary syndrome: The second leading cause of death in Canada. 2009.

STATUS lN CANADA
In contrast to USA, CPUs are not widely adopted in Canada, nor have
there been studies comparing u e of a CPU with the current unstructured
approach across hospitals. When compared with the United States, there
is evidence suggesting that the current approach is unsatisfactory due
to a higher than accepted rate of missed patients from early discharge3 .
In partial response to this, British Columbia has begun recommending
patients with possible ACS be observed in the ED and undergo serial
testing for cardiac biomarkers9 . Nevertheless, add itional evidence is
needed to convince administrators and clinicians across the country that
CPU models can be cost effective. This is particularly difficult given
the lack of common baseline performances between emergency departments in Canada.

OTHER METHODS TO IMPROVE DIAGNOSIS
Given that CPU itself is a response to the diagnostic uncertainty encountered in the ED, improvement of current diagnostic methods or strategies in the ED is also a viable option in improving patient outcome.
One method that has been studied is the use of point of care (POC) biomarkers as opposed to serial testing in patient risk stratification. In one
hospital in Thunder Bay, it was reported that the introduction of POC
biomarkers helped to reduce ad!llission and saved costs. 10 In another
multicentre trial , the use of POC assessment was linked to reductions in
hospital admissions, but the associated cost was greatly increased such
that the probability of it being cost effective was less than I 0%. This wa
due to the increased use of cardiac interventions associated with POC
biomarkers. 11 Further research is needed to evaluate whether or not these
increased interventions resu lt in addi tional patient benefits.
Similar to POC testing, Cardiac Computed Tomography (CCT) has
also been explored as an alternative to the current standard care. A single
center US study done recently included both ED costs and downstream
costs associated with CCT, and it found that CCT had a 99% probability
of costing less than the standard of care testing 12 • This was primarily due
to the differences in cost between CCT and stress testing, particularly
when stress nuclear imaging was used in the standard care. Although
promising, there are limitations associated with the use of these imaging
techniques, such as increased radiation exposure and decreased performance in patients with high body mass index . 13 In addition, there is great
variability in diagnostic accuracy across centers with this technique,
which needs to be addressed before uni versal adoption . 14
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Breastfeeding promotion: the NICU perspective
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reastfeeding is recognized as the best source of nutriti on for all
infants, and the World Health Organization (WHO) recommends
exclusive breastfeeding until 6 months of age. 1 Breast milk provides protection against infection, autoi mmune disease, and gastrointestinal dysfunction and promotes cognitive development. 2 The benefi cial
effects of breast milk can be seen even more clearl y in preterm and low
birthweight infa nts being treated in the Neonatal Intensive Care Unit
(Nl CU), where in fection and neonatal sepsis are more common. These
babies wi ll also benefit fro m the ana lgesic properties of breastfeeding
during medical procedures .1 However, studies have shown that breastfeeding rates fo r low birthweight infants are lower than their normal
birthweight counterparts. 3

B

In order to promote breastfeeding in hospitals around the world, the
WHO has developed the "Baby Friendl y Hospital Initiative" (BFHI).
This initiative provides ten steps that must be achieved before a hospital can be fo rmally accredited with BF HI status. Many successes have
been seen since the program's implementation, including an increase
in breastfeeding initiation and duration, and a decrease in inci dence of
neonatal infection and atopic eczema.4 ln Canada, the rate of breastfeeding at discharge is now at 80%, although excl usive breastfeeding rates
remain low. 1
BFHI has shown success in all hospital units, including the NICU .
An Austra lian study showed that, 4 yea rs after imp lementation, breastfeeding initiation rates in the NlCU rose fro m 35% to 75% and exclusivity at 2 weeks fro m 10% to 40%. 2 However, there has been trouble
implementi ng all te n steps in the unique NICU environment. For example, the steps include allowi ng mothers and babies to roo m together
and discouraging the use of artific ial pacifiers; these steps are often impossible in the NICU, where there are no indi vidual rooms and pac ifiers
are used to promote oral motor ski ll s in premature in fa nts.4 It has been
suggested that the WHO develop a subset of BFHI steps specifica ll y fo r
the NlCU to provide guideposts fo r hea lth wo rkers and admini strators.5
Breastfeedi ng promotion in the N ICU faces a un ique set of challenges. Because many of the in fa nts are premature, oral motor ski ll
are often poorl y developed and these in fants may display an inabi lity
to latch and suck.5·6 Th is means that mothers mu st often use manual or
electronic breast pumps to express mil k, which is then fed to the infa nt
by gavage or oral feeds. The lack of d irect suckling, comb ined with the
obvious stresses of havi ng a sick infa nt, cau e the mother 's milk suppl y
to qu ickly decline.6 To achieve an adequate milk supply, mothers may
have to pump fo r over 2 hours a day, which can itself be stressful and
exhausting.2 As we ll , the lack of electronic breast pumps and privacy
screens in the NICU can di scourage mothers from attempting to breastfeed.5
A 2007 study of factors influencing breastfeeding in the N ICU fou nd

that a lack of systemi c, consistent advice prevented mothers from initiating and maintaining breastfeeds. Women reported that, while many
NlCU nurses were knowledgeable, they had never di scussed breastfeeding wi th thei r obstetrician or neonatologist. 3 This was echoed in another
study, in which mothers reported that they received great help fro m
lactation consultants, but did not fee l that physicians were supporti ve.7
Many NICU staff still promote formu la feeding, and fo rmula companies
still sponsor many of the educati onal lectures on neonatal care.5
Another barrier to breast feeding is the design of NlCUs, which do
not promote alone time or skin-to-skin contact between mothers and infa nts. A recent study found that onl y 16% of infa nts in the NICU were
held skin-to-skin with their mothers, a practice which has been shown to
increase breast milk quantity.3 Because the NlCU is more medicalized
than other maternity wards, the focus seems to be on breast milk as a
product instead of breastfeeding as a natural process benefi cial to both
mother and infant. 7
Several strategies have been employed to try to counter the inherent
challenges of breastfeeding in the NICU . In response to mothers' complaints that thei r attempts at breastfeeding were being undermined by
the negati ve attitudes of and inconsistent advice from NICU staff, one
hospital implemented an educati onal intervention designed to improve
the breastfeeding knowledge of NICU nurses. 8 After the 8-hour educati onal session, which covered breastfeeding theory and techniques, an
analysis of pre- and post-intervention questionnaires revealed a significant increase in breastfeeding knowledge compared to control nurses
fro m other wards who did not attend the education session.8 The authors
suspected that the increased number of mothers providing breast milk
fo r their infants at the time of discharge fro m the NlCU during the year
following the interventi on was related to the nurses ' improved koowledge.8 A series of foc us groups with NICU nurses in Australia revealed
the perspecti ve that staff education was also the key to improving the
confidence of nursi ng staff so that they could fee l more comfo rtable promoti ng breastfeeding to both mothers and other colleagues, including
doctors.5
In some settings, mo thers of NICU infants may benefit fro m additi onal support beyond what is prov ided by staff; one study fo und that
hav ing access to a peer counselor (a wo man fro m the loca l communi ty
with breastfeedi ng experience who had attended a 5-day breastfeeding
course) led to 18 1% greater odds ofbreastfeeding at 12 weeks compared
to mothers who onl y received the standard of care (P=.03) .9 Peer counselors provided verbal advice or phys ically helped the mothers to breastfeed, pump, and engage in ski n-to-skin holding over a 6-week peri od .9
One hospital in West Virginia took the opportuni ty to evaluate the
impact on breastfeeding rates when it re-designed its N ICU fro m a more
traditional open-bay ward with mul ti pl e neonates in a large room to a

UWOMJ 181: 1 I Spring 2012

31

HEALTH PROMOTION
single family room (SFR) unit with a private room for each neonate.
After the re-design, 20% more infants were discharged from the NlCU
breastfeeding, and infants in the SFR received maternal breast milk on
90% of days spent in the NlCU compared to 66% of days for neonates
who stayed in the open-bay ward. 10 This improvement may have been
owed to the more private, tranquil environment of the SFR unit, which
should have enabled mothers to spend more time with their infants and
engage in more skin-to-skin contact. 10
Whenever new hospitals are built or NlCUs are renovated, designers
should attempt to maximize privacy and comfort for mother-infant pairs
to promote breastfeeding, pumping, and skin-to-skin contact. However,
limited visiting hours and having to travel large distances between home
and the hospital many continue to present significant challenges for
mothers in some settings. 11 Hospitals should ensure that all mothers with
an infant in the NlCU have access to a high quality electric breast pump
at home to maintain lactation when the mother and infant are separated.2
Despite the many barriers to successful breastfeeding that are present
in the NlCU, it is possible that the prolonged hospital stay may provide
an important opportunity for enhanced maternal breastfeeding education compared to other maternity wards where infants are discharged
from the hospital soon after birth.5 This opportunity can be augmented
through the strategies discussed above, namely improved staff education
and a peer counseling program.
The NlCU at London Health Sciences Centre (LHSC) uses a variety
of approaches to encourage mothers to breastfeed their infants. 12 The
majority of NlCU rooms have only two infant beds and curtains that
can be drawn for further privacy. Mothers are able to breastfeed, pump,
or engage in skin-to-skin contact in their infant's room, or can choose
to go to a separate room where several electric breast pumps are avai lable . Visiting hours do not apply to mothers, who are able to stay with
their neonates around the clock. Mothers are able to stay on the hospital
grounds or in the NlCU itself, eliminating the burden of having to travel
large distances between home and the hospital. However, some mothers
with other children at home may not be able to spend as much time at
LHSC.
In addition to the support and advice that mothers receive from the
NlCU's Lactation Consultant, they are provided with several pamphlets
with breastfeeding and pumping instructions, as well as charts to record
milk volume. These pamphlets and information sheets are avai lable in
several languages, and interpreters are also available if necessary. Mothers are encouraged to rent hospital-grade electric breast pumps, and a
loan program exists for mothers who cannot afford to do so . In an effort
to be as inclusive as possible, non-electric foot peddle-operated breast
pumps are avai lable for Mennonite mothers who do not have electricity
at home.

ing rates and duration in this environment. The u~e of electron.ic breast
pumps, increased staff education, and single fam1ly room des1gn h~ve
all been shown to increase the comfort and frequency of breastfeedmg
in the NICU. Many of these solutions have already been used a LHSC,
which has resulted in high rates of breastfeeding on discharge. Hopefully, widespread implementation of some of these solutions can help
promote the use of breast milk in all hospital NICUs.
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While the LHSC NlCU discharges the vast majority of its neonates
breastfeeding, it remains a challenge to get mothers to conti nue breastfeeding once they return home. This year, the hospital will begin running
a post-discharge nutrition clinic so that high-risk infants and their families can return for further support. Despite its many successfu l practices,
LHSC has not yet complied with all of the BFHI requirements. One major barrier to this achievement is that infant formula companies are sti ll
allowed to provide their product for free at LHSC (health care faci lities
must purchase formula to be BFHI-certified).
The importance of breastfeeding fo r a ll infants, and NICU infants in
particular, has been recognized aro und the world . The BFHl has provided hospitals with guidelines that can be used to promote breastfeeding
to mothers and staff alike. Even though the NlCU poses certain challenges, creative solutions have been identified to increase breastfeed-
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Interdisciplinary collaboration and relevant
perspectives in critical care: suggestions to the
medical student
Caitlin Van De Cappelle (Meds 2014), Yin Hui (Meds 2015), Alexander Van (Meds 2015)
Facuity Reviewer: Anonymous Reviewer
INTRODUCTION
Interdisciplinary collaboration plays an important role in the provision
of health care. This role is even more pronounced in intensive care settings where nurses, physicians, and other health professionals work
more closely together than other areas of the hospital. Numerous articles
in the medical literature suggest that collaborative practice in intensive
care units (ICUs) is essential to reduce patient morbidity/mortality and
improve patient outcomes. 1 Collaborative practice has the additional
benefits of reducing health care costs and improves job satisfaction for
the members of the interprofessional team . 1 While the benefits of physician-nursing collaboration in the ICU are well described in the literature, there are gaps when translating these princip les to clinical practice.
This article aims to describe current collaborative practices in the ICU
and discusses the barriers and challenges associated with this practice
model. Furthermore, we make recommendations geared towards medical students to improve collaborative practice in the ICU setting.
The meaning of ' collaboration ' or ' collaborative practice ' is not
clearly defined in critical care literature. Weiss & Davis model is commonly used, and describes collaborative practice as interactions between
nurse and physician that enable the skills and knowledge of both professionals to synergistically influence the patient care being provided. 1•2
That is to say, collaborative practice occurs when professionals work
together to provide patient care.

CURRENT COLLABORATIVE PRACTICE IN CRITICAL
CARE SETTINGS
Currently, collaborative practice and teamwork amongst interdisciplinary teams relate primarily to sharing of responsibility. Little emphasis
is placed upon coordinating decisions based on input from team members.3 Consequently, team practices tend to occur in a parallel, multidisciplinary manner, instead of involving all team members in decision
making as desired by interdisciplinary collaboration. Efforts to improve
collaboration have sought to implement ' potentially better practices
(PBPs)' , defined as evidence-based practices that have been shown to
improve outcomes in one setting, and which can be selected, modified
and applied in unique ways to fit a new situation.4 In one study, five centres were involved in a focus group studying neonatal ICU (NICU) environmental design and its impact on the neurodevelopment of neonates.5
The group identified 16 PBPs using an evidence-based approach, including tactile stimulation and developing a system for noise assessment of
the NICU acoustic environment. Collaborative development and sharing
of educational tools played a crucial role in successfully implementing
these PBPs and involved multiple professions within the intensive care
environment. 5 Moreover, the importance of interdepartmental collaboration was identified when taking suggestions from multiple caregivers
regarding noise sources in the neonates ' environment. 5

Furthermore, specific positive effects of interdisciplinary collaboration interventions have been documented in intensive care settings.6 One
study evaluated the effectiveness of collaborative decision-making processes on the process of weaning from mechanical ventilation in a medical intensive care unit. 7 Outcomes measured included length of time on
mechanical ventilation, length of stay in the intensive care unit and cost.
The study found decreased length of stay in the ICU and length of time
on the ventilator with the collaborative weaning group. There were no
significant changes in cost observed.
Another study found improvements in quality and reduction in cost
of neonatal intensive care after an interdisciplinary collaboration intervention . Teams from NICUs received instruction in quality improvement, reviewed performance data, identified common improvement
goals, and implemented ' potentially better practices ' developed through
analysis of the processes of care, literature review, and site visits. A
decrease in hospital costs was observed within the year following the
intervention.8 It is important to note that these studies may be limited
by the lack of long-term longitudinal studies to examine sustained positive effects, but suggest there are both system and patient benefits to interprofessional collaboration . In general , collaboration has led to better
patient outcomes, including reduced morbidity and mortality rates, 1 and
reduced nosocomial infections in ICUs .9

BARRIERS AND PERSPECTIVES OF COLLABORATION IN
CRITICAL CARE
It has been suggested that the attitudes of health care professionals involved in collaborative practice in critical care are pivotal to its success.
Therefore, negative attitudes can easily be detrimental and adversely affect patient care. 1•2 For example, one study found that few health care
professionals are willing to accept questioning of their decisions, especially from the nursing staff. 10 This leads to nurses further deferring
to physicians, creating conflict between the desire to be accepted and
duty to advocate for the patient. 11 The authors of this study suggest that
this internal conflict, combined with varied degrees of responsibility and
overlapping competencies can lead to 'role blurring' and confusion of
one 's expected role within the team . 12•13 Unfortunately, the professional
culture of health care has traditionally promoted hierarchical structures
with the physician in control , directly conflicting with the cited prerequisite of equal status amongst team members .12•14•15
While interprofessional collaboration is often welcomed and necessary in the intensive care setting, perspectives differ between each of the
professions involved. This difference often originates from the identity
of each profession. 12 The professional identity, including cultures, beliefs, attitudes, and behaviours, becomes ingrained during the training
process, and shapes the provider 's own problem solving approaches,
values, language, and perception of his/her role in a team .12
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model. ln order to encourage interprofessional cooperation within the
acute care setting, educational programs that promote opportunities for
multiple disciplines to work together towards a common goal have been
recomrnended.25 This may include simu lation exercise, or other team
activities as part of education and training that highlight collaboration as
a forma lly evaluated objective. Unfortunately, the majority of training
continues to be provided in isolation, supporting the idea of independent
roles and responsibilities within the health care system.

Medicine and nursing are two professions with increasingly overlapping scopes of practice that interact frequent ly during ICU care. However, the two professions are trained in different manners. Physicians
are trained to collect information and generate differential diagnoses,
and to evaluate patient outcomes in the context of the treatment plan. 12
Nurses are traditionally trained to collect data , often simultaneously
with phys icians, offer observations and impressions, and advocate for
the patients and families during their time in the ICU. 12 For example,
when the patient requires a prolonged length of stay in the ICU, the
physician 's scope of practice is often de-emphasized, and the role of the
nursing and other health professionals is highlighted e.g., weaning from
mechanical venti lation, earl y mobility, fami ly and patient support. 16•17

Lastly, we must be aware of our responsibility to foster teamwork
in our learning environments. We need to be active in seeking feedback
from preceptors and coworkers regarding our abilities to effectively
communicate and collaborate as we continue our educational journey.
By placing more attention on the perceptions and attitudes of professiona ls and creating environments that encourage professional understanding, we can begin to cultivate co ll aboration in the intensive care
unit, and beyond. This will allow health care professionals, patients and
families to profit from the established benefits of collaborative practice.

Due to the differences in professional identities and educational
training, miscommunications often arise during physician and nurse
interactions. Nurses may find that when col laborating with physicians,
physicians are unwilling to accept their input or to make changes. On the
other band, physicians may perceive nurses as defensive or aggressive
in telling them what to do fo r the patient. 18 ln some cases, physicians
may perceive collaboration as having taken place, while their nursi ng
colleagues disagree. 19 Miscommunication of differing perspecti ves can
create treatment plans that fail to address the concerns of each profession, and negatively affect the patient and fami ly's hospital stay. Additionally, collaboration may not be prioritized due to the time needed
for effective communication and coordination in addition to heavy clinical workloads .20 Despite these challenges, several things can be done to
overcome barriers and foster a collaborative work environment
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Alberta Physician Opportunities

Ponoka, Alberta (situated between Edmonton and Red Deer)
Generalist Physician interested in rehabilitation med icine needed to fill an imminent vacancy at the Halvar Jonson Centre for Bra in inj ury.
• Non progressive acquired brain injury long term rehabilitation

ALBEilTA

• Multi disciplinary rehabilitation team (OT, PT, SLP, RT, Psychology)
• Relocation allowance
• Signing bonus
• Short term on-site housing may be available
• The program will provide office space, computer, transcription service and supplies
Please Contact:
Dr. Doug Urness 403-783-7643 or Dr. Yolanda Alcaraz-Limcangco 403-783-7810
Red Deer, Alberta.
Two Adult Psychiatrists and One Child Psychiatrist needed at the Red Deer Regional Hospital
Centre (RDRHC).
•
•

~
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RDRHC serves as the Alberta Health Services Central Zone regional referral centre
A modern 373-bed facility which works collaboratively with the Centennial Centre for Mental Health and Brain Injury

The Adult Psychiatrist positions involve the provision of clinical services to 32 inpatient mental health beds as well as outpatient services in
a variety of settings.
Child and Adolescent Psychiatrist support is required for an 8-bed inpatient unit and psychiatric consultation opportunities are available in
Red Deer and surrounding Community Mental Health Centres.
Please Contact :
Dr. Doug Urness 403-783-7643 doug.urness@albertahealthservices.ca or Pamela Kathol403-309-5879 physician@albertahealthservices.ca
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The future of emergency medical care: novel
technological approaches for improved patient
management
Laura Callan (Meds 2015) and Melissa J. MacPherson , Ph .D. (Meds 2014)
Faculty Reviewer: Christine Richardson , MD, CCFP(EM) (Department of Emergency Medicine)
magine the plausible scenario of a single motor vehicle collision on
a rural highway north of London, Ontario. The 37 year o ld driver,
Willie McKeet, is the sole occupant in the vehicle traveling at approximately 80 kmlhr. Without warnin g, a deer jumps out of the bushes
in front of his car. Panicking, Mr. McKeet werves to avo id the deer,
loses control of his car and hits a tree bead-on. Another motori st witnesses the coll ision and pulls over to assess the situation. She find the
man unconscious with laceration on his fo rehead. The front airbags
have deployed and be bad been wea ring his seatbe lt. She call s 9-1 - 1. A
few minutes later, an ambulance arri ves on the scene of the colli sion. As
the paramedics are removing Mr. McKeet from his ve hicle they notice
redness and bruising on his left shoulder and what appears to be the deformi ty of hi s ri ght hip. Willie is loaded into the ambulance and dri ven
to the nearest regional hospital--a 20 minutes trip.

I

Health care techno logies are constantl y evolving and their judic ious
use can improve patient care and hospital efficiency. In this article, we
will describe several novel techno logical approaches to managing urgent patient care that may be adapted in the not too di stant future. We
wi ll fo llow the management of Will ie McKeet from the scene of a ingle
motor vehicle collision through to the operating room and explore these
emergent techno logies a long the way.
Use of emerging emergency care technologies will not begin when
Mr. McKeel reaches the emerge ncy department (ED), but rather in the
ambulance durin g transport to the hospital. Traditionally, during transport, very little could be done fo r this patient. The paramedic wo uld
assess hi s vitals, control his bleedin g, perfo rm li fe- pre erving support
as necessary and noti fy the hospital of their impending arri va l. The futuristic paramed ics who arri ved on the scene of Mr. Mc Keel's accident,
however, were equipped with an EO-link sy tern . T hi s system consi t
of two-way audi o, video and data transfer between the paramedic in the
ambulance and the emergency roo m staff at the neare t hospita l. 1 T he
portable camera allows the paramed ics to end the ED staff rea l-time
video of the cras h scene, all owing them an opportuni ty to better ga uge
the extent and type of injuries that Mr. McKeet may have su tained.
The li ve two-way voice and video a lso allow Dr. U.L. B. Fine, the ED
physician who will be treating Willi e, to better ascertain the situation by
communicating directl y with the paramedi cs.
During the twenty minute drive to the hospi tal, Dr. Fine and the
paramedics are in constant communication. The paramedics monitor
Mr. McKeet's vitals and determine that hi s blood pressure i slightl y
decrea ed, while his heart rate and res piratory rate are slightly e levated.
T hey then begin to assess his inj uri es. Willi e has lacerations on his fo rehead and bruising on his left sho ulder that continues diago nally across
his chest. Dr. Fine determ ines that the patient will need a head CT and
chest X- ray. A call is pl aced to the Radio logy Department to check the
ava il ability of the CT scanner and X-ray mac hines and alert them of the
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patient's imminent arri val. While continuing down the body, the paramedics note the deformi ty of the right hip as well as inflammation across
hi s lower abdomen where the lap belt had apparently been sitting too
high and caused constriction during impact. Dr. Fine, concerned about
both of these findin gs, asks the paramedics to use their portable ultrasound to take a look at the abdomina l cavity and determine the extent
of any internal bleeding or intestinal devascularisation, common with
seatbe lt injuries.2 Using the Focussed Assessment with Sonography for
Trauma (FAST) setting on their MobiU S device, a smartphone-based
ultrasound imaging system,3 the paramedics are able to image both the
abdomen and hip .2•4 With a c lick of a button, the paramedics send the
raw video to Dr. Fine who is able to determine that there is free flu id
around Mr. McKeet's liver and spleen. The Trauma Team leader is notifi ed and a resident, Dr. Tired, is sent to the ED to assess the patient when
he arri ves at the hospital. Furthermore, Dr. Fine and the radiologist determine that the muscles and ligaments around Mr. McKeet's hip have
not been damaged and that pelvic rad iograph is not immediately needed
upon arri val thu , saving time and resources and allowing the staff to
foc us on hi s other inj uries.
By the time the ambulance arrives at the Emergency Department
much has already been done. Mr. Mc Keet has been checked-in electronicall y by the paramedics en route to the ED using a hand he ld computer linked up to the hospita l's computer system.5 Hi s electronic health
record have already been retri eved by Nurse Amy, an ED nurse, onto
a tablet computer givi ng immediate access to a ll his health information.
She knows that he i a llergic to penicillin, is currentl y taking metformin to contro l hi type ll diabetes and has type A negati ve blood . His
emergency contact information i readil y acce ible and hi fa mily can
be contacted and in fo rmed of hi s situation. N urse Amy is able to communicate thi information to the rest of the team as Mr. McKeet is being wheeled into the trauma bay. The imagi ng result collected by the
paramedi cs are also automaticall y displayed on hand held tablets for
fu rther review by the ED staff. The team knows that Willie has abdomina l bleedin g and require furth er imaging once stabilized. They initiate
the plans they have made to ac utely manage his injuries until he can get
to an operating room. Nur e Amy has prepared severa l unit of A negati ve blood fo rtran fusion since Dr. U.L.B. Fine knew Willie would be
requiring a blood tran fusion based on his condition in the ambulance
~e l ayed by the .ER-link ystem. Once in the ED, te lemetric technology
IS used to momtor Mr. McKeet's vita l signs.H These data are automatica lly di splayed on computer screen in the trauma bay and uploaded into
hi s e lectronic medical records. Once Mr. Mc Keet ha been stabilized
he i ent for CT head and C- pine as well as CT thorax abdomen and
pelvi . :raditi ona lly, trackin g down a patient in the hospi~al is a difficult
tas k dunng treatment; ~ owever, when Willie' fa mil y arri ves panicked
m the ER, Nurse A ~y IS a?le to acti vate the electronic trackin g device
that was placed on h1 s hospita l brace let and inform the fa mil y that Willie
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is currently on his way fro m the radiology suites back to the
The
results of Mr. McKeel's CT scans are automatically sent to his electronic
health record and are viewed by Dr. Tired, the trauma resident, on his
tablet computer as he awaits Willie's return to the ED. After surgical
consultation, Mr. McKeet is sent to the operating room for surgery.
The utility of the novel technologies continues into the operati ng
room. Mr. McKeel's imaging results are displayed on large flat screen
monitors for reference during the surgery. The operating room staff use
hand held tablets to complete surgical and procedural checklists7 which
are automatically linked to Willie 's electronic health record . After the
checklists are complete, Dr. Drugs, an anaesthesiologist, uses hand-held
computing applications to verify drug information and calculate doses
for the surgical procedure.8 Once Willie is under anesthesia, the surgery
begins. The procedure is automatically filmed using a digital camera9
and a copy is linked to the electronic health record. The video can be reviewed by the surgeons for training purposes, quality control measures,
research purposes or in case of legal action. After surgery, Willie 's lab
results and further tests are continuously updated in his electronic health
record. Upon discharge Mr. McKeel's family doctor can review Willie 's
electronic health record for a detailed chronicle of his hospital stay, allowing for seamless continuity of care.
These technologies may seem futuri stic; however, several are already
in use. In a Boston Emergency Department, the SMART system has
been used to successfully monitor patient vital signs and track patients
using a gee-positioning system .5 Likewise, telemetric care has been
successfully applied to various clinical scenarios including the assessment of stroke patients while en route to hospital, 10 remote consultation
with neurology specialists from large academic centres 11 and 12-lead
EKG transmission from ambulances to cardiologists. 12 The application
of telemetric technologies would be especially useful in regions such as
Southwestern Ontario due to the large number of small rural centres and
long transit times required to reach Emergency Departments.
While these technologies are interesting in isolation , their implementation would be most beneficial in the context of an integrated approach
through an electronic medical record. These technologies could be easily implemented in our health care system; however, without a comprehensive electronic medical record system their efficacy is not as great.
We need strong physician leadership and political leadership to impl ement these technologies and revolutioni ze the deli very of emergency
medical care and improve patient management.
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An interview with Dr. Shiva Kalidindi
Joyce Zhang (Meds 2015), Lauren Sham (Meds 2014), Abdul Naeem (Meds 2014)

he was a 14 year old girl , previously healthy, who suddenly collapsed while she was running. When she was brought into the
pediatric emergency department, she was waning in and out of
consciousness. They resuscitated her, got fluids going, but it was still
unclear why she was fading in and out. Prolonged resuscitations are
challenging, but this one was particularly so because the etiology of her
cardiovascular collapse was unclear. This went on for some time. Four
hours later, while she was being transported to the ICU, she was pronounced dead . In the end, the cause of her myocardial infarction was
found upon autopsy: an anomalous coronary artery. Usually these patients would present dead to the ER. But this time, she died in spite of
their best interventions.

S

According to Dr. Shiva Kalidindi, the most challenging part of being an emergency physician is when the outcome has not gone the way
that you would like. When he has thought back to this patient, he has
wondered, "Did I do the right thing at the right time?"Medically, there
are always questions. But be knows that they did all that they cou ld do
for this patient. He takes it as a good lesson for him to improve on his
interaction with the team, as well as an opportunity to do better with
integrating the family into resuscitation care, keeping them involved and
constantly updated. This helps them in knowing that everything that can
be done for their child is being done.
Dr. Kalidindi is a Pediatric Emergency Physician at Victoria Hospital
and Associate Director of the International and Elective Program in the
Global Health Office at the Schulich School of Medicine and Dentistry.
He attended medical school at Bangalore Medical College in India and
subsequently completed his Masters in Public Health at the University
of Albany. He completed his residency and fellowship training in Pediatric Emergency Medicine at the Children 's Hospital of Michigan . He
then moved to Canada to practice about four years ago.
Choosing pediatrics was an easy decision, as this was his passion
during medical school. However, it was not until his rotation in emergency medicine during his residency that he discovered that hi s professional niche lied at the interface of pediatrics and emergency medicine. For him, the beauty and fascination of emergency medicine is the
chall enge of coming up with a diagnosis and then managing or at least
stabilizing the patient until further care is available. He loves working
with children in the emergency setting in particular because children
are relatively resilient to illnesses and they are able to recover quickly.
" Even the sickest of kids - you walk up to them and say " How are you?"
and they say "I' m fine! " with a smi le. "
As society becomes more cu lturally diverse, physicians need to be
experienced in cultural competency. This requires one to keep an open
mind, trying to understand the fami ly's values and beliefs, while ba lancing those with our desired clinical approaches and outcomes. It becomes
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particularly important when caring for a child - they usually come with
parents, if not even more fami ly members. "As long as you can set up
that common ground : the parents want their child to get better, the child
wants to go out and play, and physicians want to see their patients get
better, it becomes easier to take care of them . It's a joy." Especially in
pediatrics when it can be impossible to get a history from a child, it can
really boil down to the parent 's understanding of the child's illness .
Understanding cu ltural practices is one of the purposes of the Global Health office. In Dr. Kalidindi 's opinion, global health experiences
makes one a better physician especially when catering to a diverse population . " When you see medicine being practiced in a challenging environment, or a resource-restricted environment, it provides you a valuable perspective. We do not realize what we have here [in Canada], until
yo u see how it is in other places." Most importantly, he wants to make
international electives a meaningful experience for students. "Having an
experience is one thing, but being able to reflect on it and learn from it
is another thing." It is about being an observer as well as a contributor,
and not a barrier. He says that in order to have a meaningful contribution, one must have a dialogue with the community - see as to what their
needs are and how we can potentially address those needs. This can only
happen iftbere is su tainability to the ongoing collaboration. "What we
see as beneficial to a local community may not actually be beneficial."
Being in such a demanding specialty, Dr. Kalidindi advises that the
key is to achieve work-life balance. For him, it all comes down to the
abil ity of switching off work when work is done. Emergency medicine
gives him the luxury of being as diligent as he can be while at work, and
conver ely the abi lity to put away his pager when the shift is finished .
"Even in the most difficu lt of circumstances where I've had a challenging patient, which may or may not have gone well , I'm able to go back
home and spend quality time with my kids and my wife." He succinctly
states the advantage of working in the emergency department: "Do an
eight hour shift. Do the best you can. When you're done, you ' re done."
It is clear that Dr. Kalidindi loves what he does. "The thing with pediatric emergency is that you have a lot of gratifying moments. It 's easy
gratification . A patient might come in with a radial head subluxation a
nursemaid 's elbow. You just walk up to the patient and do a gentle twi~t.
I mean, the parents think the hand is broken or something and you ' re
able to fix it! Suddenly the kid is moving their hand and the parents
think you're a miracle maker - it's beautifu l that way." Despite all the
challenges, it's clear that pediatric emergency is where he belongs . " We
are the first to hand out popsicles and stickers in peds emerg. It's a joy
to see a child smile! " It definitely sounds like a rewarding place to be.
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Responding to an emergency- how stress affects
medical trainees
Kim Fielding (Meds 2014), Roman Shapiro (Meds 2014) and Elaine Tang (Meds 2015)
Faculty Reviewer: Dr. Lois Champion , M.D., FRCPC (Department of Anesthesia/ICU)

hether arriving as a first responder to the scene of a motor
vehicle accident or attempting to resuscitate a patient in the
emergency room, medical trainees who find themselves in an
emergency situation have to think quickly on their feet. The physiologic
stress response that occurs during such an event is influenced by many
factors. Most importantly, the individual must assess whether they have
the resources needed to so lve the problem. These include intellectual,
social, material and emotional resources. If the individual perceives that
they have the necessary resources, the situation is defined as a challenge.
On the other hand, if the individual does not fee l that they are adequately
equipped to handle the situation, they wi ll experience distress. 1

W

In any stressful event, the classic "fight-or-flight" response, described
by Walter Cannon in the 1930s, is achieved by acti vating the sympathetic nervous system. 1 The release of epinephri ne and norepi nephrine,
in a matter of seconds, results in characteristic increases in heart rate and
respiratory rate, as well as diaphoresis and increased blood pressure. In
addition, the individual may experience fee lings of anxiety. Hans Selye,
also in the 1930s, divided this response into stages: the alarm phase, in
which the individual identifies the stressor and activates the sympathetic
nervous system, the resistance phase, in which the body attempts to cope
with the stressor, and the exhaustion phase, in which the body is unable
to continue to function normally. 2

Another dimension of the stress response is the activation of the
hypothalamic-pituitary-adrenal axis and the subsequent release of cortisol into the bloodstream. This response takes longer to initiate, occurring within 5-40 minutes after the stressor is identified. The result of
the increased cortisol level is an increase in blood glucose as well as
variable effects on the brain, specifically in the amygdala, hippocampus
and prefrontal cortex. 1 The amygdala is an area of the brain thought to
be most closely associated with fear, while the hippocampus has been
demonstrated as a necessary component in activities relating to memory.
The prefrontal cortex drives executive functions, such as attention and
decision-making.
A large amount of research has been done evaluating the impact of
stress on an individual 's cognitive abi lities. Though the results seem
to be conflicting, there are some common patterns that have been described. Studies have shown that an individual 's selective attention to a
stressor may be enhanced, allowing them to block out other seemingly
irrelevant information. If the stressor is the situation at hand, as in a
need to stop bleeding in a car accident victim, then this can be viewed
as beneficial. On the contrary, if the situation at hand is intubating a
patient, but the stressor is the attending physician who is judging one 's
performance, then the attention wi ll be geared toward the physician and
not the task at hand, which could be detrimental. 2 Other researchers have
shown that tasks requiring divided attention, as in managing multiple
trauma victims, are impaired due to the stress response. 3 One proposed

mechanism for this impairment is the over activation of protein kinase
C by norepinephrine in the prefrontal cortex.4 Stress may lead medical
trainees to experience "tunnel vision" or "premature closure" in which
they do not consider all possible diagnoses in an emergency situation.2
Another area of cognition affected by stress is memory. Many experiments have demonstrated that stress impairs working memory, possibly
due to the dopamine efflux caused by cortisol in the prefrontal cortex.5
The ability of a medical trainee to remember a variety of information for
even a short period of time could be drastically impaired if the individual is in distress. Similarly, memory retrieval is significantly impaired
during stressful situations, a phenomenon linked with cortisol 's effect
on beta-2-adrenergic receptors in the hippocampus and the consequent
decrease in cAMP.6 This impairment is most notable during free recall,
as compared to recognition memory. There is some benefit of stress on
memory, nonetheless, and this is in memory consolidation . Stress has
been shown to improve memory consolidation of events specifically
linked with the stressor. 2 It is important to appreciate, however, that it is
the stressor and not necessarily the task at hand that wi ll be encoded to
long-term memory.
Stress can also impact an individual 's decision-making process, with
research showing an increase in hyper-vigilant decision-making during
stressfu l situations. 2 This is defined as impulsive, disorganized decisionmaking, with increased use of heuristics, which are experience-based
techniques for problem so lving, learning and discovery. While this may
be acceptable for an experienced physician with many well-developed
heuristics, it may not be beneficial to a medical trainee who is just beginning to form such cognitive too ls. One study involving medical radiography trainees fo und a decrease in diagnostic acc uracy associated with
increased anx iety levels.7
It is appreciated that each individual responds to stressful situations
a little differently and that unique situations may activate different neural and hormonal pathways within the same individual. Three important
factors may influence a medical trainee 's response to stress. The first is
the individual 's coping style, be it problem-focused, emotion-focused or
avoidance coping. The second is the individual 's perceived control of
the situation and whether or not there is thought to be an internal or external locus of control. Finally, the social support of the individual could
affect the stress response, with increased social support being associated
with decreased corti sol levels 2

The following scenario is a real examp le, experienced by one of the
authors, and illustrates a situation in which a medical trainee may experience significant stress.

While doing an observership in a pediatric emergency room, I was
informed by the doctor that there was a trauma case being brought in
by ambulance. Suddenly, I f elt much more awake and the entire emer-
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gency room seemed more alive. The paramedics wheeled in a boy on a
stretcher, unconscious with normal responses to pain, but not much else.
His mouth and nose were covered with blood, so a nurse passed me a
gown, gloves and a face mask, explaining, "We don't kno w what or if he
has anything. It s always better to be on the cautious side. "As I assisted
the nurse in removing the boys shoes and clothing and checking for
I. D. , I observed the doctor and other nurses assess the fundamentals of
medicine: ABC - airway, breathing, and circulation.

suppression of cAMP signalling. The Journal of Neuroscience. 20 II ; 3 1(40):
14172- 14181.
7. Cumming, S. & Harris, L. The impact of anxiety on the accuracy of diagnostic decision-making. Stress Health Journal for the International Soc1ety for
the Investigation of Stress. 200 I; 17(5): 281-286.

The patient s periphery was cool to the touch, so they brought in
warm blankets and covered him from head to toe. His blood pressure
was taken immediately by one member of the team, while someone else
checked for his pulse. The doctor cleared the airway, checked the nasal
passage to ensure there wasn 't a blockage and then assessed for breathing. The head nurse stood to one side, going systematically through all
the vitals, asking questions as different team members yelled back their
responses.
When it was recognized that the ABCs were stable, a visible tension
left the room as the secondary assessment continued. The patient had to
be moved from the spinal board to the stretcher and I was called in to
assist with supporting the patient, while the physician checked for any
visible or palpable trauma. Next, a urine lox-screen was needed, so I
was told to hold down the patient while they inserted a catheter. As the
catheter was being put in, the patient began to fight against the pain and
four people worked actively to try and hold the patient down. Finally,
the catheter was in, the urine sample taken, and the catheter removed. It
was time to fly and wake the patient up.
In my discussion with the physician after the episode, I learned a
lot of things. I realized that no one was idle in the procedure room;
eve1yone worked together as a team to help stabilize the patient. As
a first year medical student, the experience, while exhilarating, also
demonstrated to me to the necessity offo cus required during emergency
situations. There isn ~ always time to take a step back and consider all
your options. Your instincts direct you towards the vitals and as you assess those, you use key markers along the way to indicate the next step.
Though the physician was tense during the episode, stress did not seem
to impair the actions of my preceptor. I, on the other hand, felt frozen to
the spot at times and only moved when instructed to.
Ultimately, the impact of stress on one's ability to think on their feet
should not be underestimated. Medical trainees who are in distress will
experience cognitive changes that affect their attention, memory, decision-making and more. The positive outlook is that, with experience,
stress levels should decrease and, in emergency situations, one will be
better able to think quickly on their feet.
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A case of an anomalous origin of left main
coronary artery from right sinus of valsalva leading
to sudden death
Yikang Lin (Meds 2014 ), Stephen Cornish (Meds 2015)
Faculty Reviewer: Dr. Rod Lim MD (Paediatric Emergency Department)
We spend the bulk of our efforts attempting to understand the basic
framework of medicine and the top 5- l 0 entries on differential lists. And
for good reason - these are the things that we will assuredly see and have
to treat. There are always, however, going to be cases that fall outside
of the realm of the usual. These cases puzzle the best amongst our profession and make us wonder if there was anything we could have done
differently.
A young adolescent female presented to a pediatric emergency department with chest pain, shortness of breath, and cyanosis. She had
been jogging when the chest pain started, and then collapsed. Except
for a previous possible seizure or syncopal episode a few years earlier,
she was otherwise healthy. Initial vital signs were a heart rate of 58 bpm,
blood pressure of70/40 rnmHg, respiratory rate of 50 breaths/min, temperature of37°C, and oxygen saturation of68% on room air. An electrocardiogram displayed ST changes suggestive of ischemia.'
The initial presentation suggests that she was in shock - a pathophysiologic state of inadequate tissue perfusion and subsequent hypoxia.2 It is subcategorized by the underlying mechanisms: reduced blood
volume ("hypovolemic shock"), a pathological distribution of blood
volume ("distributive shock"), and/or failure of the pump ("cardiogenic
pump''). 3 If corrected quickly, the short-term effects of poor perfusion
are generally reversible.2 Prolonged shock, however, will eventually
lead to irreversible damage including cell death, end-organ damage/failure, and death .2
Typically, pediatric patients presenting with shock in the emergency
department are experiencing hypovolemic shock due to dehydration (resulting from diarrhea or osmotic diuresis) or trauma (and subsequent
hemorrhage), or distributive shock from sepsis.3 The routine work-up for
such a patient is to identify and address any life-threatening conditions
(via a rapid assessment of the patient's general appearance, breathing
quality and rate, and circulation to skin), recognize circulatory compromise, and then identify the type of shock and find the underlying cause.4
The detective work involved with this last step includes a detai led history and physical exam, combined with the necessary anci llary tests.3
Our patient's history and physical findings suggested a cardiogenic
cause of shock. One of the more alarming aspects of her presentation
was her low blood pressure and heart rate. In pediatric populations, a
low blood pressure indicates a later and more severe stage of shock.2
Clinically, shock has been described in three progressive stages. 3 The
first stage is compensated shock, in which the body 's homeostatic mechanisms (increased heart rate and peripheral vasoconstriction) are able to
maintain adequate perfusion and systolic blood pressure.2 If left untreated, compensated shock progresses to hypotensive shoe~, in which the
compensatory mechanisms are overwhelmed and there ts a subsequent
drop in systolic blood pressure along with signs of poor perfusion (e.g.
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Figure 1: Standard vs. Anomalous Origin of Coronary vessels (adapted
from reference II)
altered mental status).2 lfthe inadequate organ perfusion continues, a patient will eventually progress to irreversible shock, in which end organs
are irreparably damage, and despite resuscitation , the patient will die. 2
To prevent the progression through these stages of shock, current
guidelines advise an aggressive, multi-pronged treatment algorithm
aimed at improving perfusion and end organ function .4 The first arm is
rapid fluid resuscitation using isotonic crystalloid solution.4 Early vascular access is needed to facilitate fluid resuscitation efforts. Another
treatment arm is airway and respiratory support in the form of supplemental oxygen, positive pressure ventilation, and/or intubation.4 Monitoring of physiological indicators (including blood pressure, quality of
pulses, skin perfusion, mental status, and renal output) before and after
interventions provide additional clues to the type and underlying causes
of shock.3 This information would direct the final arm of treatment, the
selection of appropriate medications.4
Our patient exhausted the available treatment modalities. She was
started with peripheral venous lines.' Gravity alone was not enough
to push the requisite amount of fluid .5 Direct pressure on the bag and
"push-pull" method were employed to maximize fluid delivery. Additional vascular lines were established using bilateral intraosseous (IO)
infusions into her proximal tibias.' These infusions take advantage of
the veins that drain the medullary sinus of long bones.5 Due to their
support from the bony-matrix, these veins do not collapse. After cannulation to gain access to the medullary sinus using a large bore needle
and drill, and flushing with normal saline, an IO has equivalent infusion
rates to a 21 gauge peripheral intravenous catheter.5 She was placed on
supplemental oxygen, intubated, and given inotropic medications (dopamine at 5-20mcglkg/min, norepinephrine at 0.05-0.5mcglkg/min, and
epinephrine at 0.1-3.0 meg/kg/min).' Her cardiac output deteriorated,
and eventually resuscitation attempts were discontinued .'
The post-mortem examination of the heart revealed an anomalous
origin of the left main coronary artery (LMCA) from the right sinus of
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Valsalva. 1 The precipitating cau e of death for our patient was determined to be acute myocardial ischemia. The standard shock management regimen was not sufficient to treat her condition, and parts of the
administered therapy may have been detrimental.
Under normal circumstances, there are two sinuses ofValsalva arising
from the aorta distal to the aortic valve. Anomalous origin of coronary
arteries (AOCA) is a rare (estimated 0.1-0.3% prevalence)6 congenital
heart defect,7 in which coronary vessel(s) follow an abnorma l route (see
Figure 1). Our patient's left main coronary artery arose from the right
sinus, passed between the pulmonary trunk and ascending aorta, before
supplying its dependent heart tissue. Despite its low prevalence, AOCA
is the second leading cause of sudden death in young athletes, representing approximately I 0% of deaths in this population 6 This discrepancy
may be due to a high mortality rate associated with thi s condition and/or
the under diagnosis of this condition (affected individuals are typically
asymptomatic during daily activities of living).
AOCA is often included in the differential for sudden cardiac deaths
in young - albeit as a diagnosis of exclusion . Even so, when the condition actuall y causes a coronary event due to the insufficient oxygen
delivery when placed under stre s, it presentation is very difficult to
discern from other conditions that cause similar symptoms. 8 Most cases
are identified upon autopsy, where myocardial fibrosis in the chronically under-perfused heart ti ssue and signs of hyper-acute myocardial
infarction may be evident. In our case, the young gi rl was given inotropic agents in order to increase her cardiac output by increasing force of
ventricular contraction. 1 Howeve r, unbeknownst to the physicians, these
agents furth er enlarged her pulmonary trunk and aorta upon each heartbeat, further occluding her LM CA, and thus exacerbating the ischemia
of the heart musc le.
A case like our patient's wi ll always beg the question, what could
have been done differentl y? The rea lity of thi s case is that AOCA is incredibly difficult to identify, especially in the emergency setting.9 However, there is always something that can be gained from evaluating any
and all aspects of the case in order to gain wisdom and knowledge to
aid us in future patient care . In this case, there were a few clues. The
fir t clue was her history. From the literature, the myocardial infarction
in individuals with AOCA is often preceded by a period of trenuous
exercise. 7 Our patient was in her teens, otherwise healthy, and had been
jogging before experiencing non-specific chest pain , followed by collapse and loss of consc iousne s. Exertional syncope is always more concerning than non-exertional. In conjunction wi th her response to treatment, this presentation may have rai ed suspicion of a myriad of cardiac
conditions, including AOCA. More importantly, on further questi oning,
the initial presentati on had been preci pitated by exertion . She had fully
recovered from that incident, but if she had been sent for further eva luation it is possible that the defect may have been detected before he
had a second syncopal episode, and may have been surgica lly corrected.
Heart function tests includ ing the ECGs and ejection fractions that
were done for our patient have not been demon !rated to be helpful di agnostic tools for coronary artery anomalies. 10 Imagi ng, however, all ows
physicians to note the presence of a congenital defect in the origin of the
coronary, follow the artery's unusual course, and assess the integrity of
the artery by looking for region of tenosis. One of the best methods to
identify this anomaly is the use of computed tomographi c angiography
(CTA) to visuali ze the displaced coronary artery. Thi s type of imagi ng is
unfortunately not practical in such an emergency setting. Transthoracic
and transesophagea l echocardi ography have also been demonstrated to
be feasi bl e and practical in you ng patients, and these imaging modalities can be u ed to justify ordering a CTA scan. 10 Our patie nt did get
an emergent echocardiogram during active resuscitation, but the vesse ls
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were not clearly visualized. 1
Upon identification of the anomaly, treatment is possible t~ough
surgical means. Coronary artery bypass grafting (CABG) remams ~he
standard treatment in these instances, with some surgical teams electmg
5
to also ' un-roof' the associated anomalous coronary artery. This technique involves modifying the ostium of the coronary artery by excising
(' un-roofing ') the common wall between the aorta and anomalous artery.
Attempts to re-implant the anomalous vessel into the correct aortic sinus
have been completed, but are technically challenging and are not yet indicated over the safer surgical alternatives. Our patient was never stable
enough to consider this option.
The medical profession is ripe with challenges for practicing physicians. One of the most mentally difficult tasks required of physicians
is the need to maintain an expert knowledge of countless medical conditions, many of which are exceedingly uncommon epidemiologically.
Losing a patient who could have been helped by the correct treatment
if the proverbial "zebras" had been recognized in time is a true test of a
physician 's confidence, and is a stark reminder that the science and art
of medicine demands perfection fro m imperfect people.
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Larrey's Revolution
Jason L. Chan (MD/PhD 2017) and Justine Denomme (Meds 2015)
Faculty Reviewer: Dr. Paul Potter, MD, PhD (Department of History of Medicine)

uly 14, 1789. "To arms! " echoed throughout Paris. The city was
in a state of unrest and angry mobs roamed the streets. Spurred on
by discontent with the monarchy and nobility, Parisians were seeking to gather large quantities of arms and ammunition . This ultimately
culminated in the storming of the Bastille, an imposing fortress and a
symbol of monarchical oppression. Its capture galvanized revolutionaries and helped justify their cause. The French Revolution was beginning.

J

The French Revolution and the following Napoleonic era transformed the social and political structure of Europe. In three years,
France's long-standing monarchy was abolished . The aristocracy and
clergy were stripped of authority as class distinctions were eliminated
and democracy was established. Ideas of liberty, equality, and citizenship prevailed. The Revolution also marked the beginning of over two
decades of war that consumed Europe. Revolutionary ideals resonated
with people beyond France and well after the end of the Napo leonic
Wars. This period of change and turmoil affected all aspects of human
life worldwide, and medicine was no exception.
Indeed, the medical profession contributed to the Revolution and
was forever changed by it. For Dominique Jean Larrey (1766-1842),
the storming of the Bastille was a defining moment. On July 14, 1789,
he led a contingent of 1500 medical students:
I put myself at the head of these young men .. . and we were the
first to march against the tyrants . .. Everyone armed himself as
best as he could and we marched through the night inciting the
populace to rebellion. On the morning of the fourteenth we armed
ourselves at the lnvalides and turned our steps towards the Bastille. If we did not have the honour of mounting the first assault, it
was only because the immense crowd before the gates prevented
us, and not because we lacked either the enthusiasm or the courage.'
Larrey would soon become a surgeon in the army of the French revolutionary government and later, surgeon-in-chief to Napoleon Bonaparte's Imperial Guard. He strongly believed in the values ofthe Revolution
and was an idealist. 1•2 While these characteristics created challenges in
his military career, they fuelled his determination to provide compassionate and humanitarian care for the wounded. Today, he is considered
the father of emergency medicine. Social revolution and years of war
created the circumstances necessary for Larrey to implement and develop an unprecedented medical system.

PRE-REVOLUTION
Before the French Revolution, medical care was largely absent for
wounded soldiers. Military operations and manoeuvres had absolute priority and military commanders believed the wounded simply interfered
with their battle plans.1•3 Physicians and surgeons seldom belonged in
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armies and responsibility for care fell to fellow soldiers, local inhabitants, and camp-followers. ' Wagons were used to remove the wounded
after a battle ended, but were required to wait four ki lometres behind
the army and never arrived in less than twenty-four to thirty-six hourS .4 ' 5
Regulations denied immediate treatment and evacuation, 1 and soldiers
often died waiting. Compounding the problem was the status of medical
officers employed to oversee collection of the wounded. The officers
were often surgeons, poorly paid, and did not have military rank or authority.1 ·2·6 Surgeons overall belonged to the barber class, were seen as
inferior to physicians, and lacked social and political power. 7

REVOLUTION
The French Revolution had important social implications for surgeons.
Traditionally trained through apprenticeships and removed from positions of privilege, they opposed the monarchy and its institutions. Revolutionary France saw a reorganization of universities and medical education, with surgeons at the forefront, emphasizing practical learning.7
Nonetheless, their newfound prominence in education and civilian life
was not readily applied to the battlefield. For military medicine, it was a
case of plus ya change, plus c 'est Ia rnerne chose. 1
Meanwhile, warfare at the beginning of the Revolution was becoming increasingly violent. Casualties were produced on a large scale as a
result of military conscription, massive troop formations , and the use of
concentrated artillery and accurate musketry. 8•9 Furthermore, the rise of
Napoleon ushered in a disregard for military conventions dictating the
conclusion of battles and procedures for surrender. Instead, armies were
to be annihilated. The conditions of war created a greater need for medicine to be present, but without a change in the culture of military medicine, the wounded would continue to be overlooked. Military medicine
required an individual to take initiative and challenge military authority.
Dominique Jean Larrey was moved by the unnecessary deaths he
witnessed on the battlefield in 1792 1·5 and resolved to change the military mindset. He once reflected that " the misfortune of others affect me
strongly. Serious disasters affl ict my sou l and plunge me into the deepest grief; I often think I can do something to help, and even attempt to
remedy the situation." 2 Fortunately, his conviction, driven by Revolutionary ideals, was aided by the Revolution itself. The Reign of Terror
was underway and stipulated that anyone caught opposing the Revolution would be sentenced to death . It enforced Revolutionary values, of
which equality for all citizens was paramount. Military generals were
compelled to accept Larrey's proposals and give him permission and
authority to implement his ideas.'

INNOVATION
Larrey wanted to deliver prompt treatment and evacuation to casualties
on the battlefield. He recognized that delaying treatment complicated
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patient cases, and lead to hemorrhage, increased pain, infection, and
death.8 In particular, he went against the predominant practice of waiting
as long as twenty days to amputate and advocated for surgery within the
first few hours after injury.2•3•10 lnspired by the quickness and mobility of
flying artillery, cannons attached to horse-drawn carriages, Larrey created the ambulances volantes, or flying ambu lances.
The concept of flying ambulances was first tested in 1793 10 and approved in 1794.5 There would be two types. A two-wheel model could
carry two soldiers and was suited for use on flat terrain, while a fourwheel model could carry four lying casualties and travel across mountains. 4•5 In addition to providing transport, they were equipped for onthe-spot surgery and medical treatment.' ' The flying ambulances became
the core of Larrey 's system of medical care.
Each ambulance unit consisted of a surgeon-in-chief and three divisions of 113 people and 12 flying ambulances.4 • 10 Larrey was careful
to include military officers and soldiers in his ambulance teams, since
medical officers alone did not have any authority on the battlefield. 1
Whether the situation demanded immediate treatment or evacuation, the
ambulances would eventually converge at dressing stations or hospitals
set up at the rear.
Unfortunately, due to political opposition to Larrey 's plans, his system did not debut until 1797 in the presence of Napoleon Bonaparte.
Napoleon was impressed and praised Larrey: "Your work is one of the
greatest conceptions of our age. It alone will suffice to ensure your reputation."' The future French emperor 's admiration and support of Larrey 's work helped the flying ambulance system achieve success. The
presence of flying ambulances in the military boosted the morale and
confidence of French soldiers. 10 Unsurprisingly, they adored Larrey and
called him "The Saviour." 4 • 10
The implementation of flying ambulances was accompanied with
the conception and development of systems of triage. The multitude of
casualties, the range of injury severities, and limited resources created
a necessity for the sorting ofpatients.5 First and foremost, Larrey explicitly instructed his medical officers to " always start with the most dangerously injured, without regard to rank or distinction ."' This applied to
both treatment and evacuation . Larrey was also known for providing
the same quality of care to enemy wounded .3.6·' 2 On resource management and military rank, Larrey noted, "The slightly wounded can go to
the hospital in the first and second line, especially officers because the
officers have horses." 10 With triage, Larrey created a complete, efficient,
and organized medical system for those wounded in battle when there
was none to begin with .
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EMERGENCY MEDICINE
Larrey's unprecedented medical system was esta blished through his determination, and through the circumstances created by the French Revolution and its subsequent wars . His flyin g ambulances are precur ors
to the modem ambulance. The basic concepts of triage have remained
unchanged 13 and are integral to modem e mergency rooms, disaster management, and military medicine. Hi s system reflected the fundamental
principles of emergency medicine by providing immediate response,
transport to care stati o ns, care en route, and medical and surgical treatment. Dominique Jean Larrey introduced emergency medicine to the
world and, with it, revolutionized the way warfare was perceived . The
wounded were no longer ignored and humanity prevai led despite the
inhumanities of war.
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